Distributions of all expression values and Top 1% of expressed Intron features for libraries: ABC_RG012, ABC_RG016, ABC_RG015, ABC_RG046, ABC_RG047, ABC_RG048, ABC_RG049, ABC_RG058, ABC_RG059, ABC_RG061, ABC_RG073, ABC_RG074, ABC_RG086, GCB_RG003, GCB_RG005, GCB_RG006, GCB_RG007, GCB_RG010, GCB_RG014, GCB_RG045, GCB_RG050, GCB_RG055, GCB_RG062, GCB_RG063, GCB_RG064, GCB_RG071, GCB_RG072, GCB_RG069, GCB_RG085
Download data matrix file (Intron x library): IntronExpression_v57.txt.gz
Distribution of log2 expression values for library: ABC_RG012 and data type: Intron
Distribution of all expression values for the feature type: Intron. Note that unlike in the individual gene pages these log2 expression values were not adjusted by adding 1 before converting to log2 scale. This results in -ve expression values if the average coverage of the feature was less than 1 before conversion to log2 scale. The 95th percentile of Silent Intergenic regions is reported to give an indication of the level of background expression noise. *If you can not see the figure below, click here
Distribution of log2 expression values for library: ABC_RG016 and data type: Intron
Distribution of all expression values for the feature type: Intron. Note that unlike in the individual gene pages these log2 expression values were not adjusted by adding 1 before converting to log2 scale. This results in -ve expression values if the average coverage of the feature was less than 1 before conversion to log2 scale. The 95th percentile of Silent Intergenic regions is reported to give an indication of the level of background expression noise. *If you can not see the figure below, click here
Distribution of log2 expression values for library: ABC_RG015 and data type: Intron
Distribution of all expression values for the feature type: Intron. Note that unlike in the individual gene pages these log2 expression values were not adjusted by adding 1 before converting to log2 scale. This results in -ve expression values if the average coverage of the feature was less than 1 before conversion to log2 scale. The 95th percentile of Silent Intergenic regions is reported to give an indication of the level of background expression noise. *If you can not see the figure below, click here
Distribution of log2 expression values for library: ABC_RG046 and data type: Intron
Distribution of all expression values for the feature type: Intron. Note that unlike in the individual gene pages these log2 expression values were not adjusted by adding 1 before converting to log2 scale. This results in -ve expression values if the average coverage of the feature was less than 1 before conversion to log2 scale. The 95th percentile of Silent Intergenic regions is reported to give an indication of the level of background expression noise. *If you can not see the figure below, click here
Distribution of log2 expression values for library: ABC_RG047 and data type: Intron
Distribution of all expression values for the feature type: Intron. Note that unlike in the individual gene pages these log2 expression values were not adjusted by adding 1 before converting to log2 scale. This results in -ve expression values if the average coverage of the feature was less than 1 before conversion to log2 scale. The 95th percentile of Silent Intergenic regions is reported to give an indication of the level of background expression noise. *If you can not see the figure below, click here
Distribution of log2 expression values for library: ABC_RG048 and data type: Intron
Distribution of all expression values for the feature type: Intron. Note that unlike in the individual gene pages these log2 expression values were not adjusted by adding 1 before converting to log2 scale. This results in -ve expression values if the average coverage of the feature was less than 1 before conversion to log2 scale. The 95th percentile of Silent Intergenic regions is reported to give an indication of the level of background expression noise. *If you can not see the figure below, click here
Distribution of log2 expression values for library: ABC_RG049 and data type: Intron
Distribution of all expression values for the feature type: Intron. Note that unlike in the individual gene pages these log2 expression values were not adjusted by adding 1 before converting to log2 scale. This results in -ve expression values if the average coverage of the feature was less than 1 before conversion to log2 scale. The 95th percentile of Silent Intergenic regions is reported to give an indication of the level of background expression noise. *If you can not see the figure below, click here
Distribution of log2 expression values for library: ABC_RG058 and data type: Intron
Distribution of all expression values for the feature type: Intron. Note that unlike in the individual gene pages these log2 expression values were not adjusted by adding 1 before converting to log2 scale. This results in -ve expression values if the average coverage of the feature was less than 1 before conversion to log2 scale. The 95th percentile of Silent Intergenic regions is reported to give an indication of the level of background expression noise. *If you can not see the figure below, click here
Distribution of log2 expression values for library: ABC_RG059 and data type: Intron
Distribution of all expression values for the feature type: Intron. Note that unlike in the individual gene pages these log2 expression values were not adjusted by adding 1 before converting to log2 scale. This results in -ve expression values if the average coverage of the feature was less than 1 before conversion to log2 scale. The 95th percentile of Silent Intergenic regions is reported to give an indication of the level of background expression noise. *If you can not see the figure below, click here
Distribution of log2 expression values for library: ABC_RG061 and data type: Intron
Distribution of all expression values for the feature type: Intron. Note that unlike in the individual gene pages these log2 expression values were not adjusted by adding 1 before converting to log2 scale. This results in -ve expression values if the average coverage of the feature was less than 1 before conversion to log2 scale. The 95th percentile of Silent Intergenic regions is reported to give an indication of the level of background expression noise. *If you can not see the figure below, click here
Distribution of log2 expression values for library: ABC_RG073 and data type: Intron
Distribution of all expression values for the feature type: Intron. Note that unlike in the individual gene pages these log2 expression values were not adjusted by adding 1 before converting to log2 scale. This results in -ve expression values if the average coverage of the feature was less than 1 before conversion to log2 scale. The 95th percentile of Silent Intergenic regions is reported to give an indication of the level of background expression noise. *If you can not see the figure below, click here
Distribution of log2 expression values for library: ABC_RG074 and data type: Intron
Distribution of all expression values for the feature type: Intron. Note that unlike in the individual gene pages these log2 expression values were not adjusted by adding 1 before converting to log2 scale. This results in -ve expression values if the average coverage of the feature was less than 1 before conversion to log2 scale. The 95th percentile of Silent Intergenic regions is reported to give an indication of the level of background expression noise. *If you can not see the figure below, click here
Distribution of log2 expression values for library: ABC_RG086 and data type: Intron
Distribution of all expression values for the feature type: Intron. Note that unlike in the individual gene pages these log2 expression values were not adjusted by adding 1 before converting to log2 scale. This results in -ve expression values if the average coverage of the feature was less than 1 before conversion to log2 scale. The 95th percentile of Silent Intergenic regions is reported to give an indication of the level of background expression noise. *If you can not see the figure below, click here
Distribution of log2 expression values for library: GCB_RG003 and data type: Intron
Distribution of all expression values for the feature type: Intron. Note that unlike in the individual gene pages these log2 expression values were not adjusted by adding 1 before converting to log2 scale. This results in -ve expression values if the average coverage of the feature was less than 1 before conversion to log2 scale. The 95th percentile of Silent Intergenic regions is reported to give an indication of the level of background expression noise. *If you can not see the figure below, click here
Distribution of log2 expression values for library: GCB_RG005 and data type: Intron
Distribution of all expression values for the feature type: Intron. Note that unlike in the individual gene pages these log2 expression values were not adjusted by adding 1 before converting to log2 scale. This results in -ve expression values if the average coverage of the feature was less than 1 before conversion to log2 scale. The 95th percentile of Silent Intergenic regions is reported to give an indication of the level of background expression noise. *If you can not see the figure below, click here
Distribution of log2 expression values for library: GCB_RG006 and data type: Intron
Distribution of all expression values for the feature type: Intron. Note that unlike in the individual gene pages these log2 expression values were not adjusted by adding 1 before converting to log2 scale. This results in -ve expression values if the average coverage of the feature was less than 1 before conversion to log2 scale. The 95th percentile of Silent Intergenic regions is reported to give an indication of the level of background expression noise. *If you can not see the figure below, click here
Distribution of log2 expression values for library: GCB_RG007 and data type: Intron
Distribution of all expression values for the feature type: Intron. Note that unlike in the individual gene pages these log2 expression values were not adjusted by adding 1 before converting to log2 scale. This results in -ve expression values if the average coverage of the feature was less than 1 before conversion to log2 scale. The 95th percentile of Silent Intergenic regions is reported to give an indication of the level of background expression noise. *If you can not see the figure below, click here
Distribution of log2 expression values for library: GCB_RG010 and data type: Intron
Distribution of all expression values for the feature type: Intron. Note that unlike in the individual gene pages these log2 expression values were not adjusted by adding 1 before converting to log2 scale. This results in -ve expression values if the average coverage of the feature was less than 1 before conversion to log2 scale. The 95th percentile of Silent Intergenic regions is reported to give an indication of the level of background expression noise. *If you can not see the figure below, click here
Distribution of log2 expression values for library: GCB_RG014 and data type: Intron
Distribution of all expression values for the feature type: Intron. Note that unlike in the individual gene pages these log2 expression values were not adjusted by adding 1 before converting to log2 scale. This results in -ve expression values if the average coverage of the feature was less than 1 before conversion to log2 scale. The 95th percentile of Silent Intergenic regions is reported to give an indication of the level of background expression noise. *If you can not see the figure below, click here
Distribution of log2 expression values for library: GCB_RG045 and data type: Intron
Distribution of all expression values for the feature type: Intron. Note that unlike in the individual gene pages these log2 expression values were not adjusted by adding 1 before converting to log2 scale. This results in -ve expression values if the average coverage of the feature was less than 1 before conversion to log2 scale. The 95th percentile of Silent Intergenic regions is reported to give an indication of the level of background expression noise. *If you can not see the figure below, click here
Distribution of log2 expression values for library: GCB_RG050 and data type: Intron
Distribution of all expression values for the feature type: Intron. Note that unlike in the individual gene pages these log2 expression values were not adjusted by adding 1 before converting to log2 scale. This results in -ve expression values if the average coverage of the feature was less than 1 before conversion to log2 scale. The 95th percentile of Silent Intergenic regions is reported to give an indication of the level of background expression noise. *If you can not see the figure below, click here
Distribution of log2 expression values for library: GCB_RG055 and data type: Intron
Distribution of all expression values for the feature type: Intron. Note that unlike in the individual gene pages these log2 expression values were not adjusted by adding 1 before converting to log2 scale. This results in -ve expression values if the average coverage of the feature was less than 1 before conversion to log2 scale. The 95th percentile of Silent Intergenic regions is reported to give an indication of the level of background expression noise. *If you can not see the figure below, click here
Distribution of log2 expression values for library: GCB_RG062 and data type: Intron
Distribution of all expression values for the feature type: Intron. Note that unlike in the individual gene pages these log2 expression values were not adjusted by adding 1 before converting to log2 scale. This results in -ve expression values if the average coverage of the feature was less than 1 before conversion to log2 scale. The 95th percentile of Silent Intergenic regions is reported to give an indication of the level of background expression noise. *If you can not see the figure below, click here
Distribution of log2 expression values for library: GCB_RG063 and data type: Intron
Distribution of all expression values for the feature type: Intron. Note that unlike in the individual gene pages these log2 expression values were not adjusted by adding 1 before converting to log2 scale. This results in -ve expression values if the average coverage of the feature was less than 1 before conversion to log2 scale. The 95th percentile of Silent Intergenic regions is reported to give an indication of the level of background expression noise. *If you can not see the figure below, click here
Distribution of log2 expression values for library: GCB_RG064 and data type: Intron
Distribution of all expression values for the feature type: Intron. Note that unlike in the individual gene pages these log2 expression values were not adjusted by adding 1 before converting to log2 scale. This results in -ve expression values if the average coverage of the feature was less than 1 before conversion to log2 scale. The 95th percentile of Silent Intergenic regions is reported to give an indication of the level of background expression noise. *If you can not see the figure below, click here
Distribution of log2 expression values for library: GCB_RG071 and data type: Intron
Distribution of all expression values for the feature type: Intron. Note that unlike in the individual gene pages these log2 expression values were not adjusted by adding 1 before converting to log2 scale. This results in -ve expression values if the average coverage of the feature was less than 1 before conversion to log2 scale. The 95th percentile of Silent Intergenic regions is reported to give an indication of the level of background expression noise. *If you can not see the figure below, click here
Distribution of log2 expression values for library: GCB_RG072 and data type: Intron
Distribution of all expression values for the feature type: Intron. Note that unlike in the individual gene pages these log2 expression values were not adjusted by adding 1 before converting to log2 scale. This results in -ve expression values if the average coverage of the feature was less than 1 before conversion to log2 scale. The 95th percentile of Silent Intergenic regions is reported to give an indication of the level of background expression noise. *If you can not see the figure below, click here
Distribution of log2 expression values for library: GCB_RG069 and data type: Intron
Distribution of all expression values for the feature type: Intron. Note that unlike in the individual gene pages these log2 expression values were not adjusted by adding 1 before converting to log2 scale. This results in -ve expression values if the average coverage of the feature was less than 1 before conversion to log2 scale. The 95th percentile of Silent Intergenic regions is reported to give an indication of the level of background expression noise. *If you can not see the figure below, click here
Distribution of log2 expression values for library: GCB_RG085 and data type: Intron
Distribution of all expression values for the feature type: Intron. Note that unlike in the individual gene pages these log2 expression values were not adjusted by adding 1 before converting to log2 scale. This results in -ve expression values if the average coverage of the feature was less than 1 before conversion to log2 scale. The 95th percentile of Silent Intergenic regions is reported to give an indication of the level of background expression noise. *If you can not see the figure below, click here
Top 1% of expressed Intron features
The following table provides a ranked list of the most highly expressed Intron features. Each column corresponds to an expression library. Each table cell contains the Gene Name (which links to the ALEXA-Seq gene record), followed by the Feature Name (which links to the feature's coordinates in the UCSC Genome Browser and displays expression data), the log2 expression value 'Exp' for the feature, and the percent expression value '% Exp' ([feature expression/gene expression]*100). For Gene records the percent displayed here represents the percentage of all reads for the library instead. Features that are NOT supported by an EST/mRNA sequence are indicated in bold. For exon junction features the number of exons skipped by the junction is indicated as 'Sn', where n is the number of exons skipped (e.g. S0 means no exons skipped, S1 means one exon skipped, etc.).
| RANK | ABC_RG012 (Gene | Feature | Exp | % Exp) | ABC_RG016 (Gene | Feature | Exp | % Exp) | ABC_RG015 (Gene | Feature | Exp | % Exp) | ABC_RG046 (Gene | Feature | Exp | % Exp) | ABC_RG047 (Gene | Feature | Exp | % Exp) | ABC_RG048 (Gene | Feature | Exp | % Exp) | ABC_RG049 (Gene | Feature | Exp | % Exp) | ABC_RG058 (Gene | Feature | Exp | % Exp) | ABC_RG059 (Gene | Feature | Exp | % Exp) | ABC_RG061 (Gene | Feature | Exp | % Exp) | ABC_RG073 (Gene | Feature | Exp | % Exp) | ABC_RG074 (Gene | Feature | Exp | % Exp) | ABC_RG086 (Gene | Feature | Exp | % Exp) | GCB_RG003 (Gene | Feature | Exp | % Exp) | GCB_RG005 (Gene | Feature | Exp | % Exp) | GCB_RG006 (Gene | Feature | Exp | % Exp) | GCB_RG007 (Gene | Feature | Exp | % Exp) | GCB_RG010 (Gene | Feature | Exp | % Exp) | GCB_RG014 (Gene | Feature | Exp | % Exp) | GCB_RG045 (Gene | Feature | Exp | % Exp) | GCB_RG050 (Gene | Feature | Exp | % Exp) | GCB_RG055 (Gene | Feature | Exp | % Exp) | GCB_RG062 (Gene | Feature | Exp | % Exp) | GCB_RG063 (Gene | Feature | Exp | % Exp) | GCB_RG064 (Gene | Feature | Exp | % Exp) | GCB_RG071 (Gene | Feature | Exp | % Exp) | GCB_RG072 (Gene | Feature | Exp | % Exp) | GCB_RG069 (Gene | Feature | Exp | % Exp) | GCB_RG085 (Gene | Feature | Exp | % Exp) |
| 1 | RP5-857K21.2 | I5 | 10.68 | 0% | SOD2 | I5 | 12.73 | 0% | H2AFX | I1 | 9.88 | 131.49% | RP5-857K21.2 | I5 | 10.94 | 0% | PDK1 | I15 | 11.00 | 0% | SOD2 | I5 | 12.22 | 0% | MOBKL1B | I10 | 10.52 | 115.97% | RP5-857K21.2 | I5 | 11.51 | 0% | RP5-857K21.2 | I5 | 11.50 | 0% | MOBKL1B | I10 | 10.47 | 0% | SOD2 | I5 | 11.51 | 0% | RP5-857K21.2 | I5 | 10.21 | 0% | SOD2 | I5 | 10.06 | 81.30% | DDX5 | I11 | 10.55 | 35.66% | RP5-857K21.2 | I5 | 11.66 | 0% | RP5-857K21.2 | I5 | 11.62 | 0% | DDX5 | I11 | 11.64 | 52.70% | SOD2 | I5 | 11.13 | 203.80% | SOD2 | I5 | 10.07 | 0% | RP5-857K21.2 | I5 | 12.20 | 0% | SOD2 | I5 | 11.42 | 0% | RP5-857K21.2 | I5 | 12.90 | 0% | RP5-857K21.2 | I5 | 10.00 | 312446.70% | RP5-857K21.2 | I5 | 11.47 | 0% | RP5-857K21.2 | I5 | 11.73 | 0% | RP5-857K21.2 | I5 | 10.43 | 0% | MOBKL1B | I10 | 11.22 | 0% | AC096579.1 AC096579.3 | Ix | 10.57 | 0% | RP5-857K21.2 | I5 | 10.60 | 0% |
| 2 | MOBKL1B | I10 | 9.96 | 0% | RP5-857K21.2 | I5 | 11.82 | 0% | AP000944.1 | I1 | 9.42 | 95.48% | ITGAE AC087742.1 | Ix | 10.55 | 0% | RP5-857K21.2 | I5 | 10.77 | 0% | MOBKL1B | I10 | 11.03 | 0% | RP5-857K21.2 | I5 | 9.79 | 112170.83% | MOBKL1B | I10 | 9.54 | 0% | OR2I1P | I1 | 9.94 | 0% | OR2I1P | I1 | 10.38 | 0% | MOBKL1B | I10 | 11.23 | 0% | MOBKL1B | I10 | 9.75 | 0% | MOBKL1B | I10 | 9.96 | 143.32% | MOBKL1B | I10 | 10.32 | 127.09% | DDX5 | I11 | 11.33 | 0% | DDX5 | I11 | 10.64 | 0% | IGHV3-6 | I25 | 11.38 | 3210.35% | RPL27 | I1 | 11.02 | 38.67% | MOBKL1B | I10 | 10.03 | 0% | MOBKL1B | I10 | 10.19 | 0% | RP5-857K21.2 | I5 | 10.86 | 0% | SOD2 | I5 | 9.86 | 0% | MOBKL1B | I10 | 9.67 | 152.76% | DDX5 | I11 | 10.09 | 0% | MOBKL1B | I10 | 10.52 | 0% | RP5-857K21.2 | I5 | 9.90 | 0% | SOD2 | I5 | 10.98 | 0% | RP5-857K21.2 | I5 | 10.35 | 0% | RP5-857K21.2 | I5 | 9.99 | 0% |
| 3 | AP000944.1 | I1 | 9.69 | 0% | MOBKL1B | I10 | 10.34 | 0% | IGHG2 | I2 | 9.22 | 26.80% | MOBKL1B | I10 | 10.45 | 0% | CCR2 | I3 | 10.55 | 0% | RP5-857K21.2 | I5 | 10.99 | 0% | ITGAE AC087742.1 | Ix | 9.00 | 179.64% | RP5-857K21.2 | I5 | 8.85 | 0% | MOBKL1B | I10 | 9.89 | 0% | SOD2 | I5 | 10.35 | 0% | RP5-857K21.2 | I5 | 10.11 | 0% | CUGBP1 | I15 | 9.11 | 0% | H2AFX | I1 | 9.42 | 84.98% | RP5-857K21.2 | I5 | 10.25 | 373282.53% | MOBKL1B | I10 | 10.06 | 0% | MOBKL1B | I10 | 10.54 | 0% | IGHV3-6 | I25 | 11.10 | 2637.65% | AP000944.1 | I1 | 10.01 | 91.26% | H2AFX | I1 | 9.67 | 0% | AC011450.2 CD37 | Ix | 9.52 | 0% | MOBKL1B | I10 | 10.69 | 0% | FTL | I3 | 9.57 | 0% | RP5-857K21.2 | I5 | 9.21 | 180853.26% | MOBKL1B | I10 | 9.81 | 0% | RP5-857K21.2 | I5 | 10.06 | 0% | PSMB7 | I12 | 9.67 | 0% | RP5-857K21.2 | I5 | 10.12 | 0% | RP5-857K21.2 | I5 | 9.88 | 0% | MOBKL1B | I10 | 9.32 | 0% |
| 4 | SOD2 | I5 | 9.63 | 0% | RP5-857K21.2 | I5 | 9.95 | 0% | D87015.1 SC-9C5.1 D86994.3 BCRL4 | Ix | 9.08 | 70.01% | IGHV3-6 | I26 | 9.49 | 0% | C11orf48 | I4 | 10.45 | 0% | OR2I1P | I1 | 10.12 | 0% | AC012379.2 SHC4 | Ix | 8.88 | 75.25% | NAPSB | I5 | 8.48 | 0% | RP5-857K21.2 | I5 | 9.83 | 0% | RP5-857K21.2 | I5 | 9.36 | 0% | RP5-857K21.2 | I5 | 10.01 | 0% | RP5-857K21.2 | I5 | 9.03 | 0% | KHSRP | I20 | 8.90 | 69.16% | PSMB7 | I12 | 10.03 | 208.42% | SFRS5 | I5 | 9.67 | 0% | RP5-857K21.2 | I5 | 10.17 | 0% | IGHV3-6 | I22 | 10.68 | 1975.35% | MOBKL1B | I10 | 9.89 | 115.24% | NAP1L1 | I13 | 9.57 | 0% | DDX5 | I11 | 9.45 | 0% | RP5-857K21.2 | I5 | 10.28 | 0% | CD74 | I8 | 9.33 | 0% | SOD2 | I5 | 8.80 | 154.62% | RP5-857K21.2 | I5 | 9.72 | 0% | DDX5 | I11 | 9.61 | 0% | MOBKL1B | I10 | 9.34 | 0% | PTPN1 | I9 | 9.36 | 0% | SYVN1 | I2 | 9.85 | 0% | SYVN1 | I2 | 8.89 | 0% |
| 5 | MS4A1 | I4 | 9.49 | 0% | OR2I1P | I1 | 9.67 | 0% | SOD2 | I5 | 8.90 | 140.79% | DDX5 | I11 | 9.23 | 0% | TMSB10 C2orf89 | Ix | 9.87 | 0% | RP5-857K21.2 | I5 | 9.98 | 0% | CCR2 | I3 | 8.75 | 62.27% | IGHV3-6 | I25 | 8.41 | 0% | FAM65B | I16 | 9.34 | 0% | RP5-857K21.2 | I5 | 9.17 | 0% | PTPN1 | I9 | 9.93 | 0% | AC011450.2 CD37 | Ix | 8.86 | 0% | CUGBP1 | I15 | 8.76 | 256.32% | SOD2 | I5 | 9.48 | 158.60% | DDX5 | I12 | 9.51 | 0% | HNRPDL | I7 | 9.89 | 0% | IGHV3-6 | I24 | 10.66 | 1952.47% | DDX5 | I11 | 9.55 | 27.50% | DDX5 | I11 | 9.43 | 0% | CD74 | I8 | 8.77 | 0% | RP11-154D6.1 | I5 | 9.51 | 0% | H2AFX | I1 | 9.16 | 0% | AC012379.2 SHC4 | Ix | 8.56 | 61.94% | SOD2 | I5 | 9.29 | 0% | PSMB7 | I12 | 9.59 | 0% | KHSRP | I20 | 8.95 | 0% | AC231380.2 TRBC1 | Ix | 8.83 | 0% | MOBKL1B | I10 | 9.47 | 0% | SOD2 | I5 | 8.79 | 0% |
| 6 | DDX5 | I11 | 9.47 | 0% | DDX5 | I11 | 9.20 | 0% | CUGBP1 | I15 | 8.87 | 147.60% | SFRS5 | I5 | 9.02 | 0% | MOBKL1B | I10 | 9.77 | 0% | DDX5 | I11 | 9.85 | 0% | AC231380.2 TRBC1 | Ix | 8.71 | 256.76% | DDX5 | I11 | 8.32 | 0% | PCBD2 | I3 | 9.23 | 0% | DDX5 | I11 | 9.03 | 0% | OR2I1P | I1 | 9.58 | 0% | SOD2 | I5 | 8.85 | 0% | PTPN1 | I9 | 8.75 | 23.19% | OR2I1P | I1 | 9.38 | 172.25% | NAP1L1 | I13 | 9.23 | 0% | AC011450.2 CD37 | Ix | 9.83 | 0% | IGHV3-6 | I26 | 10.61 | 1876.95% | SFRS5 | I5 | 9.38 | 60.82% | PAFAH1B2 | I6 | 9.13 | 0% | NAP1L1 | I13 | 8.71 | 0% | RP11-154D6.1 | I4 | 9.32 | 0% | MOBKL1B | I10 | 9.12 | 0% | PAFAH1B2 | I6 | 8.48 | 65.71% | APLNR | I1 | 9.28 | 0% | SOD2 | I5 | 9.30 | 0% | AC011450.2 CD37 | Ix | 8.82 | 0% | FAM65B | I16 | 8.79 | 0% | AC096579.1 AC096579.3 | Ix | 9.43 | 0% | KHSRP | I20 | 8.60 | 0% |
| 7 | RP5-857K21.2 | I5 | 9.25 | 0% | NAPSB | I5 | 8.75 | 0% | DDX5 | I11 | 8.86 | 25.03% | RPL30 | I3 | 8.66 | 0% | PDLIM3 | I5 | 9.41 | 0% | HNRNPH1 | I4 | 9.18 | 0% | H2AFX | I1 | 8.38 | 79.36% | CFLAR | I20 | 8.32 | 0% | DDX5 | I11 | 9.08 | 0% | CUGBP1 | I15 | 8.69 | 0% | MACROD2 | I24 | 9.21 | 0% | PTPN1 | I9 | 8.83 | 0% | OR2I1P | I1 | 8.55 | 189.96% | CD1C | I4 | 9.28 | 30.91% | TEX9 | I12 | 9.08 | 0% | DDX5 | I12 | 9.78 | 0% | AC011450.2 CD37 | Ix | 10.38 | 21.77% | FADS3 | I8 | 9.26 | 43.82% | SFRS5 | I5 | 9.11 | 0% | CD22 | I12 | 8.68 | 0% | RP11-154D6.1 | I6 | 9.00 | 0% | OR2I1P | I1 | 8.73 | 0% | AC007620.1 | I1 | 8.41 | 111.95% | BTN3A2 | I11 | 9.20 | 0% | CD74 | I8 | 9.11 | 0% | BAX | I6 | 8.76 | 0% | UBE2H | I10 | 8.71 | 0% | CUGBP1 | I15 | 8.77 | 0% | PAFAH1B2 | I6 | 8.30 | 0% |
| 8 | AC011450.2 CD37 | Ix | 9.19 | 0% | FTL | I3 | 8.55 | 0% | KHSRP | I20 | 8.85 | 71.65% | PFDN5 | I2 | 8.58 | 0% | AC096579.1 AC096579.3 | Ix | 9.08 | 0% | FTL | I3 | 8.99 | 0% | SOD2 | I5 | 8.35 | 106.65% | RPS2 | I1 | 8.30 | 0% | D87015.1 SC-9C5.1 D86994.3 BCRL4 | Ix | 9.01 | 0% | PTPN1 | I9 | 8.69 | 0% | NAPSB | I5 | 8.98 | 0% | OR2I1P | I1 | 8.82 | 0% | PAFAH1B2 | I6 | 8.43 | 113.78% | SFRS5 | I5 | 8.99 | 51.41% | ITGAE AC087742.1 | Ix | 9.06 | 0% | PSMB7 | I12 | 9.68 | 0% | AC016525.1 | I1 | 10.15 | 99.24% | MKNK2 | I3 | 9.04 | 30.27% | TIPRL | I8 | 8.70 | 0% | FTL | I3 | 8.56 | 0% | KHSRP | I20 | 8.94 | 0% | NKG7 | I2 | 8.49 | 0% | CUGBP1 | I15 | 8.12 | 106.13% | DDX5 | I12 | 9.20 | 0% | AC011450.2 CD37 | Ix | 8.99 | 0% | CUGBP1 | I15 | 8.52 | 0% | AC012652.3 AC012652.5 | Ix | 8.68 | 0% | PARP10 | I7 | 8.58 | 0% | AC011450.2 CD37 | Ix | 8.27 | 0% |
| 9 | D87015.1 SC-9C5.1 D86994.3 BCRL4 | Ix | 9.06 | 0% | FAM65B | I16 | 8.53 | 0% | D87015.1 SC-9C5.1 D86994.3 BCRL4 | Ix | 8.84 | 59.25% | MYBL2 | I11 | 8.57 | 0% | MYBL2 | I11 | 9.07 | 0% | DDX5 | I12 | 8.91 | 0% | RP11-149B7.3 | I1 | 8.18 | 114.08% | DOK3 | I7 | 8.26 | 0% | SOD2 | I5 | 8.93 | 0% | BTN3A2 | I11 | 8.58 | 0% | AC012652.3 AC012652.5 | Ix | 8.59 | 0% | NAPSB | I5 | 8.70 | 0% | AC012652.3 AC012652.5 | Ix | 8.10 | 138.38% | CD1C | I5 | 8.97 | 24.97% | MED12L | I19 | 8.98 | 0% | SFRS5 | I5 | 9.57 | 0% | IGHV3-6 | I23 | 10.13 | 1353.85% | HNRPDL | I7 | 8.94 | 104.40% | H2AFV | I5 | 8.69 | 0% | CD22 | I2 | 8.52 | 0% | RP11-149B7.3 | I1 | 8.74 | 0% | GNAI2 | I12 | 8.39 | 0% | MTO1 | I11 | 8.08 | 649.10% | SFRS5 | I5 | 9.09 | 0% | OR2I1P | I1 | 8.47 | 0% | SOD2 | I5 | 8.42 | 0% | RP5-857K21.2 | I5 | 8.66 | 0% | AC034193.2 | I1 | 8.51 | 0% | RPL30 | I3 | 8.23 | 0% |
| 10 | PKM2 | I11 | 8.96 | 0% | RP11-149B7.3 | I1 | 8.52 | 0% | MOBKL1B | I10 | 8.80 | 162.50% | CEACAM21 | I1 | 8.17 | 0% | SORBS2 | I46 | 8.85 | 0% | HNRPDL | I7 | 8.85 | 0% | CFLAR ALS2CR10 | Ix | 8.13 | 121.88% | TRAF4 | I8 | 8.22 | 0% | D87015.1 SC-9C5.1 D86994.3 BCRL4 | Ix | 8.85 | 0% | AC012379.2 SHC4 | Ix | 8.56 | 0% | FAM65B | I16 | 8.52 | 0% | DDX5 | I11 | 8.64 | 0% | C11orf48 | I4 | 7.65 | 41.14% | RP5-857K21.2 | I5 | 8.79 | 135891.44% | CD22 | I12 | 8.91 | 0% | CD53 | I7 | 9.53 | 0% | IGHV3-6 | I22 | 9.98 | 1214.90% | NEIL1 | I5 | 8.88 | 76.26% | FAM65B | I16 | 8.62 | 0% | CD22 | I1 | 8.50 | 0% | AP000944.1 | I1 | 8.48 | 0% | RP5-857K21.2 | I5 | 8.36 | 0% | H2AFX | I1 | 8.00 | 85.66% | SAT1 | I2 | 8.73 | 0% | IGHG2 | I2 | 8.28 | 0% | OR2I1P | I1 | 8.38 | 0% | TROVE2 | I10 | 8.55 | 0% | KHSRP | I20 | 8.45 | 0% | AC105446.1 TRIM56 | Ix | 8.20 | 0% |
| 11 | D87015.1 SC-9C5.1 D86994.3 BCRL4 | Ix | 8.88 | 0% | HNRNPH1 | I4 | 8.51 | 0% | D87015.1 SC-9C5.1 D86994.3 BCRL4 | Ix | 8.75 | 55.80% | HNRNPH1 | I4 | 8.15 | 0% | RP5-857K21.2 | I5 | 8.81 | 0% | AP000944.1 | I1 | 8.84 | 0% | SFRS5 | I5 | 8.06 | 35.76% | SFRS5 | I5 | 8.08 | 0% | FTL | I3 | 8.77 | 0% | AC011450.2 CD37 | Ix | 8.45 | 0% | CUGBP1 | I15 | 8.46 | 0% | U2AF1L4 | I5 | 8.52 | 0% | BAX | I6 | 7.61 | 32.04% | BTNL9 | I6 | 8.45 | 99.08% | HNRPDL | I7 | 8.90 | 0% | CD74 | I8 | 9.43 | 0% | SFRS5 | I5 | 9.95 | 68.57% | HNRNPH1 | I4 | 8.84 | 52.33% | RPS25 | I2 | 8.54 | 0% | SFRS5 | I5 | 8.47 | 0% | H2AFX | I1 | 8.34 | 0% | KHSRP | I20 | 8.20 | 0% | IGHV3-6 | I26 | 8.00 | 59.91% | CD74 | I8 | 8.63 | 0% | IGHV3-6 IGHM | Ix | 8.23 | 0% | UBE2H | I10 | 8.36 | 0% | RPL30 | I3 | 8.41 | 0% | SLC25A15 | I8 | 8.36 | 0% | PSMB7 | I12 | 8.14 | 0% |
| 12 | B2M | I3 | 8.87 | 0% | AC012652.3 AC012652.5 | Ix | 8.43 | 0% | OR2I1P | I1 | 8.69 | 106.40% | CFLAR ALS2CR10 | Ix | 8.12 | 0% | PDLIM3 | I7 | 8.70 | 0% | PTPN1 | I9 | 8.82 | 0% | TMEM49 | I11 | 7.99 | 21.17% | AC011450.2 CD37 | Ix | 8.05 | 0% | CUGBP1 | I15 | 8.74 | 0% | H2AFX | I1 | 8.43 | 0% | AC011450.2 CD37 | Ix | 8.36 | 0% | D87015.1 SC-9C5.1 D86994.3 BCRL4 | Ix | 8.52 | 0% | RP11-149B7.3 | I1 | 7.54 | 86.08% | AP000944.1 | I1 | 8.40 | 70.83% | AC096579.1 AC096579.3 | Ix | 8.87 | 0% | HNRNPH1 | I4 | 9.39 | 0% | HNRNPH1 | I4 | 9.63 | 70.76% | HNRNPH1 | I3 | 8.78 | 50.37% | KHSRP | I20 | 8.53 | 0% | C10orf104 | I4 | 8.46 | 0% | PAFAH1B2 | I6 | 8.31 | 0% | DOK3 | I7 | 7.98 | 0% | MKNK2 | I3 | 7.96 | 23.04% | FTL | I3 | 8.58 | 0% | DDX5 | I12 | 8.17 | 0% | RGS8 | I10 | 8.26 | 0% | PAFAH1B2 | I6 | 8.39 | 0% | AC012379.2 SHC4 | Ix | 8.23 | 0% | OR2I1P | I1 | 7.80 | 0% |
| 13 | TCIRG1 | I5 | 8.86 | 0% | SAT1 | I2 | 8.40 | 0% | PTPN1 | I9 | 8.63 | 22.41% | FAM129C | I4 | 8.00 | 0% | UBE2D3 | I1 | 8.70 | 0% | HNRNPH1 | I3 | 8.74 | 0% | AC034193.2 | I1 | 7.97 | 170.89% | BCAT1 | I8 | 8.02 | 0% | AP000944.1 | I1 | 8.69 | 0% | KHSRP | I20 | 8.40 | 0% | RP11-149B7.3 | I1 | 8.27 | 0% | H2AFX | I1 | 8.38 | 0% | CSNK2A2 | I11 | 7.51 | 47.57% | AC012652.3 AC012652.5 | Ix | 8.36 | 131.58% | CD53 | I8 | 8.76 | 0% | CD53 | I6 | 9.22 | 0% | RP5-857K21.2 | I5 | 9.61 | 46944.90% | NEIL1 | I6 | 8.76 | 70.15% | HNRPDL | I7 | 8.47 | 0% | PFDN5 | I2 | 8.41 | 0% | AC012652.3 AC012652.5 | Ix | 8.29 | 0% | HOPX | I3 | 7.71 | 0% | IGHV3-6 IGHM | Ix | 7.91 | 56.53% | HNRPDL | I7 | 8.54 | 0% | MICAL2 | I27 | 8.17 | 0% | FCRLB | I4 | 8.19 | 0% | FNBP1 | I23 | 8.37 | 0% | SYNE2 | I113 | 8.22 | 0% | TMSB4X | I1 | 7.73 | 0% |
| 14 | PKM2 | I10 | 8.83 | 0% | HNRPDL | I7 | 8.38 | 0% | FAM65B | I16 | 8.37 | 62.02% | H2AFX | I1 | 7.99 | 0% | IGHV3-6 IGHV3-9 | Ix | 8.52 | 0% | SFRS5 | I5 | 8.69 | 0% | TIPRL | I8 | 7.91 | 53.50% | CD74 | I4 | 8.00 | 0% | HNRNPH1 | I4 | 8.63 | 0% | IL16 | I21 | 8.37 | 0% | U2AF1L4 | I5 | 8.18 | 0% | AC105446.1 TRIM56 | Ix | 8.31 | 0% | BTN3A2 | I11 | 7.48 | 74.90% | HNRPDL | I7 | 8.28 | 78.88% | SLC6A16 | I11 | 8.75 | 0% | HNRNPH1 | I3 | 9.21 | 0% | CD1C | I4 | 9.60 | 63.10% | CUGBP1 | I15 | 8.72 | 137.87% | TMPO | I4 | 8.41 | 0% | DOK3 | I7 | 8.32 | 0% | SGK1 | I19 | 8.27 | 0% | BTN3A2 | I11 | 7.68 | 0% | DUSP22 AL357054.1 | Ix | 7.87 | 48.06% | ACADVL | I10 | 8.45 | 0% | UBE2H | I10 | 8.05 | 0% | DDX5 | I11 | 8.18 | 0% | CD74 | I8 | 8.37 | 0% | SLC25A15 | I8 | 8.16 | 0% | FTL | I3 | 7.70 | 0% |
| 15 | CD74 | I8 | 8.80 | 0% | AL035670.1 | I1 | 8.38 | 0% | DOK3 | I7 | 8.32 | 148.28% | SOD2 | I5 | 7.99 | 0% | NDUFC1 AC116610.1 | Ix | 8.51 | 0% | RP11-149B7.3 | I1 | 8.61 | 0% | OR2I1P | I1 | 7.90 | 218.39% | PFDN5 | I2 | 7.96 | 0% | KHSRP | I20 | 8.55 | 0% | AC012652.3 AC012652.5 | Ix | 8.33 | 0% | BTN3A2 | I11 | 8.16 | 0% | RP11-149B7.3 | I1 | 8.21 | 0% | U2AF1L4 | I5 | 7.43 | 84.16% | BTNL9 | I9 | 8.24 | 86.01% | TROVE2 | I10 | 8.64 | 0% | CD53 | I8 | 9.16 | 0% | HNRNPH1 | I3 | 9.56 | 67.67% | NEIL1 | I7 | 8.72 | 68.02% | HNRNPH1 | I4 | 8.38 | 0% | H2AFX | I1 | 8.32 | 0% | MED1 | I17 | 8.26 | 0% | C11orf48 | I4 | 7.60 | 0% | OR2I1P | I1 | 7.79 | 178.43% | KHSRP | I20 | 8.41 | 0% | IGHV3-6 | I25 | 8.03 | 0% | SYVN1 | I2 | 8.01 | 0% | OR2I1P | I1 | 8.34 | 0% | AC096579.1 AC096579.3 | Ix | 8.16 | 0% | BTN3A2 | I11 | 7.65 | 0% |
| 16 | SFRS5 | I5 | 8.79 | 0% | SFRS5 | I5 | 8.37 | 0% | IL16 | I21 | 8.20 | 47.61% | AC012652.3 AC012652.5 | Ix | 7.98 | 0% | NAP1L1 | I13 | 8.26 | 0% | CUGBP1 | I15 | 8.60 | 0% | STIM2 | I1 | 7.88 | 279.03% | PKM2 | I10 | 7.93 | 0% | AP000944.1 | I2 | 8.46 | 0% | NAPSB | I5 | 8.32 | 0% | CSNK2A2 | I11 | 8.16 | 0% | D87015.1 SC-9C5.1 D86994.3 BCRL4 | Ix | 8.16 | 0% | TROVE2 | I10 | 7.33 | 219.85% | KHSRP | I20 | 8.20 | 58.39% | FADS3 | I8 | 8.64 | 0% | AC096579.3 | I27 | 9.15 | 0% | MOBKL1B | I10 | 9.54 | 112.49% | H2AFX | I1 | 8.72 | 92.22% | AC096579.1 AC096579.3 | Ix | 8.33 | 0% | CD1C | I4 | 8.31 | 0% | FNBP1 | I23 | 8.21 | 0% | RPL30 | I3 | 7.46 | 0% | DOK3 | I7 | 7.78 | 191.72% | HNRNPH1 | I4 | 8.41 | 0% | AC012652.3 AC012652.5 | Ix | 8.01 | 0% | AC034193.2 | I1 | 7.95 | 0% | RP11-149B7.3 | I1 | 8.13 | 0% | UBE2H | I10 | 8.08 | 0% | CUGBP1 | I15 | 7.63 | 0% |
| 17 | FTL | I3 | 8.76 | 0% | FCRL5 | I10 | 8.36 | 0% | UBE2H | I10 | 8.15 | 150.29% | AC011450.2 CD37 | Ix | 7.93 | 0% | C11orf83 | I1 | 8.24 | 0% | SAT1 | I2 | 8.45 | 0% | AP000944.1 | I1 | 7.56 | 52.47% | PKM2 | I11 | 7.90 | 0% | SFRS5 | I5 | 8.45 | 0% | HNRNPH1 | I4 | 8.28 | 0% | IGHV3-6 KIAA0125 | Ix | 8.06 | 0% | D87015.1 SC-9C5.1 D86994.3 BCRL4 | Ix | 8.13 | 0% | SLC25A15 | I8 | 7.27 | 102.26% | CUGBP1 | I15 | 8.18 | 99.65% | AC011450.2 CD37 | Ix | 8.63 | 0% | CD74 | I4 | 8.92 | 0% | HNRPDL | I7 | 9.37 | 137.98% | IGHV3-6 | I26 | 8.70 | 648.46% | TROVE2 | I10 | 8.33 | 0% | RPL27A | I1 | 8.27 | 0% | CUGBP1 | I15 | 8.21 | 0% | PTPN1 | I9 | 7.44 | 0% | AFAP1 | I16 | 7.75 | 506.96% | SRRM2 | I13 | 8.39 | 0% | CD74 | I7 | 7.98 | 0% | RPL30 | I3 | 7.92 | 0% | BCAT1 | I8 | 8.11 | 0% | SFRS5 | I5 | 8.07 | 0% | H2AFX | I1 | 7.62 | 0% |
| 18 | D87015.1 SC-9C5.1 D86994.3 BCRL4 | Ix | 8.72 | 0% | AP000944.1 | I2 | 8.32 | 0% | D87015.1 SC-9C5.1 D86994.3 BCRL4 | Ix | 8.07 | 34.71% | CD53 | I7 | 7.92 | 0% | ANKRD37 | I4 | 8.12 | 0% | KHSRP | I20 | 8.35 | 0% | EIF2AK4 | I38 | 7.56 | 244.73% | AC010619.2 | I2 | 7.87 | 0% | D87015.1 SC-9C5.1 D86994.3 BCRL4 | Ix | 8.42 | 0% | P2RX5 | I11 | 8.19 | 0% | KHSRP | I20 | 7.98 | 0% | FAM65B | I16 | 8.02 | 0% | AC009060.6 | I2 | 7.22 | 569.29% | UBE2H | I10 | 8.17 | 117.39% | HNRNPH1 | I4 | 8.59 | 0% | CD53 | I5 | 8.88 | 0% | FCRL1 | I2 | 9.32 | 62.70% | ARHGEF18 | I20 | 8.68 | 115.33% | HNRNPH1 | I3 | 8.32 | 0% | PTPRB | I27 | 8.14 | 0% | TMEM49 | I11 | 8.20 | 0% | RPL27 | I1 | 7.37 | 0% | SYVN1 | I2 | 7.73 | 32.43% | B2M | I3 | 8.35 | 0% | BTNL9 | I6 | 7.91 | 0% | H2AFX | I1 | 7.82 | 0% | CSNK2A2 | I11 | 7.93 | 0% | SNRPD3 | I4 | 8.06 | 0% | DDX5 | I11 | 7.59 | 0% |
| 19 | CD53 | I7 | 8.67 | 0% | AL035670.1 TDRD6 | Ix | 8.26 | 0% | AP000944.1 | I2 | 7.98 | 35.12% | AP000944.1 | I1 | 7.90 | 0% | CNOT7 | I6 | 8.07 | 0% | SFRS6 | I3 | 8.32 | 0% | PDK1 | I15 | 7.49 | 83.06% | CD74 | I8 | 7.85 | 0% | TROVE2 | I10 | 8.42 | 0% | FAM65B | I16 | 8.19 | 0% | HNRNPH1 | I4 | 7.89 | 0% | KHSRP | I20 | 7.85 | 0% | SLC25A15 | I8 | 7.21 | 98.33% | BTN3A2 | I11 | 8.15 | 93.32% | TIPRL | I8 | 8.59 | 0% | HLA-DPB1 | I4 | 8.83 | 0% | IGHV3-6 | I22 | 9.31 | 764.91% | AP000944.1 | I2 | 8.65 | 35.40% | DDX5 | I12 | 8.30 | 0% | TPT1 | I2 | 8.14 | 0% | PSMB7 | I12 | 8.19 | 0% | AC011450.2 CD37 | Ix | 7.30 | 0% | COL5A1 | I64 | 7.58 | 75.68% | UBE2H | I10 | 8.33 | 0% | KHSRP | I20 | 7.86 | 0% | FTL | I3 | 7.80 | 0% | KHSRP | I20 | 7.90 | 0% | DOK3 | I7 | 8.04 | 0% | PRPF40B | I18 | 7.59 | 0% |
| 20 | FADS3 | I8 | 8.61 | 0% | PAFAH1B2 | I6 | 8.24 | 0% | IL16 | I20 | 7.86 | 37.45% | TIPRL | I8 | 7.84 | 0% | AC096579.3 | I1 | 8.06 | 0% | PAFAH1B2 | I6 | 8.27 | 0% | ATP8B1 | I18 | 7.46 | 2624.91% | RPL17 | I1 | 7.75 | 0% | AC034193.2 | I1 | 8.38 | 0% | RP11-149B7.3 | I1 | 8.13 | 0% | AC007620.1 | I1 | 7.88 | 0% | HNRNPH1 | I3 | 7.81 | 0% | MED1 | I17 | 7.20 | 149.82% | HNRNPH1 | I4 | 8.10 | 31.70% | TMSB4X | I1 | 8.55 | 0% | OR2I1P | I1 | 8.80 | 0% | CIITA | I19 | 9.28 | 77.89% | TAS1R1 | I2 | 8.62 | 43.34% | OR2I1P | I1 | 8.27 | 0% | PTPRB | I26 | 8.12 | 0% | DDX5 | I11 | 8.17 | 0% | CYBASC3 | I3 | 7.21 | 0% | CSNK2A2 | I11 | 7.52 | 55.54% | GNAI2 | I12 | 8.33 | 0% | SFRS5 | I5 | 7.79 | 0% | FCRLB | I3 | 7.78 | 0% | PSMB7 | I12 | 7.89 | 0% | WNK2 | I18 | 7.90 | 0% | AC096579.3 IGKV3-20 | Ix | 7.56 | 0% |
| 21 | CD74 | I4 | 8.61 | 0% | DDX5 | I12 | 8.17 | 0% | BAX | I6 | 7.62 | 26.30% | CD53 | I6 | 7.82 | 0% | H2AFV | I5 | 8.05 | 0% | AP000944.1 | I2 | 8.21 | 0% | PARP15 | I7 | 7.41 | 54.80% | IL17RB | I8 | 7.71 | 0% | PARP15 | I7 | 8.37 | 0% | SFRS5 | I5 | 8.12 | 0% | PAFAH1B2 | I6 | 7.79 | 0% | HNRNPH1 | I4 | 7.80 | 0% | C14orf45 | I18 | 6.98 | 2635.99% | DOK3 | I7 | 8.09 | 186.92% | SGK1 | I19 | 8.53 | 0% | HLA-DPB1 | I3 | 8.77 | 0% | AP000944.1 | I1 | 9.20 | 62.04% | PAFAH1B2 | I6 | 8.60 | 68.34% | AC012652.3 AC012652.5 | Ix | 8.27 | 0% | SFRS6 | I3 | 8.10 | 0% | PTPN1 | I9 | 8.15 | 0% | RPL9 | I1 | 7.20 | 0% | COL5A1 | I65 | 7.43 | 68.38% | TROVE2 | I10 | 8.21 | 0% | U2AF1L4 | I5 | 7.74 | 0% | RP5-857K21.2 | I5 | 7.77 | 0% | MICAL2 | I27 | 7.86 | 0% | PSMB7 | I12 | 7.87 | 0% | PRPF40B | I16 | 7.56 | 0% |
| 22 | AP000944.1 | I2 | 8.56 | 0% | RP11-149B7.3 AL136219.3 | Ix | 8.16 | 0% | SFRS5 | I5 | 7.57 | 27.99% | SLC37A1 | I8 | 7.81 | 0% | ITGAE AC087742.1 | Ix | 7.90 | 0% | BTN3A2 | I11 | 8.20 | 0% | BTN3A2 | I11 | 7.39 | 82.69% | SUSD2 | I11 | 7.67 | 0% | CD74 | I8 | 8.34 | 0% | CD74 | I8 | 8.08 | 0% | MED1 | I17 | 7.74 | 0% | CSNK2A2 | I11 | 7.79 | 0% | AC007620.1 | I1 | 6.95 | 77.07% | HNRNPH1 | I3 | 8.06 | 30.65% | NAPSB | I5 | 8.51 | 0% | AC096579.1 AC096579.3 | Ix | 8.76 | 0% | SRRM2 | I13 | 8.99 | 32.77% | AC012379.2 SHC4 | Ix | 8.58 | 75.92% | CSNK2A2 | I11 | 8.25 | 0% | PTPRB | I24 | 8.09 | 0% | RGS1 | I3 | 8.07 | 0% | MMP20 | I5 | 7.11 | 0% | AC012652.3 AC012652.5 | Ix | 7.39 | 96.50% | AC011450.2 CD37 | Ix | 8.19 | 0% | BTN3A2 | I11 | 7.70 | 0% | CD22 | I1 | 7.75 | 0% | IL16 | I20 | 7.80 | 0% | HECW2 | I30 | 7.87 | 0% | NAP1L1 | I13 | 7.52 | 0% |
| 23 | TMSB10 C2orf89 | Ix | 8.50 | 0% | AP000944.1 | I1 | 8.15 | 0% | IGHV3-6 IGHM | Ix | 7.39 | 55.72% | IGHV3-6 KIAA0125 | Ix | 7.79 | 0% | RP11-149B7.3 | I1 | 7.87 | 0% | B2M | I3 | 8.18 | 0% | PANK2 | I10 | 7.35 | 491.07% | CYBASC3 | I3 | 7.67 | 0% | HNRPDL | I7 | 8.33 | 0% | PAFAH1B2 | I6 | 8.03 | 0% | SNRPD3 | I4 | 7.71 | 0% | AP000944.1 | I1 | 7.72 | 0% | U2AF1L4 | I8 | 6.95 | 60.26% | C17orf62 | I3 | 8.05 | 37.80% | SAT1 | I2 | 8.49 | 0% | CD74 | I7 | 8.74 | 0% | NAPSB | I5 | 8.98 | 37.99% | SFRS6 | I3 | 8.56 | 84.74% | RGS13 | I2 | 8.25 | 0% | SOD2 | I5 | 8.09 | 0% | HNRNPH1 | I4 | 8.05 | 0% | CPNE5 | I22 | 7.09 | 0% | UBE2H | I10 | 7.32 | 128.37% | PCSK7 | I16 | 8.18 | 0% | MICAL2 | I26 | 7.69 | 0% | APLNR | I1 | 7.72 | 0% | H2AFX | I1 | 7.72 | 0% | SERPINA9 | I1 | 7.86 | 0% | AC034193.2 | I1 | 7.49 | 0% |
| 24 | D87015.1 SC-9C5.1 D86994.3 BCRL4 | Ix | 8.48 | 0% | PAQR3 | I10 | 8.10 | 0% | LRRC61 | I5 | 7.25 | 106.63% | P2RX5 | I11 | 7.76 | 0% | RPL27 | I1 | 7.87 | 0% | NAP1L1 | I13 | 8.15 | 0% | ATP8B1 | I17 | 7.35 | 2433.94% | RPL27 | I1 | 7.64 | 0% | BTN3A2 | I11 | 8.31 | 0% | AP000944.1 | I1 | 7.97 | 0% | DDX5 | I11 | 7.61 | 0% | AC087742.1 ATP2A3 | Ix | 7.68 | 0% | AC105446.1 TRIM56 | Ix | 6.95 | 452.98% | HECW2 | I30 | 7.96 | 641.96% | ACADVL | I10 | 8.44 | 0% | B2M | I3 | 8.68 | 0% | AC116552.2 CYBA | Ix | 8.85 | 22.64% | RP5-857K21.2 | I5 | 8.54 | 40049.64% | RPL30 | I3 | 8.23 | 0% | TCIRG1 | I5 | 7.94 | 0% | FTL | I3 | 8.01 | 0% | AC034193.2 | I1 | 7.00 | 0% | MTO1 RP11-505P4.2 | Ix | 7.32 | 42.97% | AC012652.3 AC012652.5 | Ix | 8.17 | 0% | APLNR | I1 | 7.69 | 0% | HECW2 | I30 | 7.72 | 0% | NAP1L1 | I13 | 7.72 | 0% | AC231380.2 TRBC1 | Ix | 7.84 | 0% | UBE2H | I10 | 7.31 | 0% |
| 25 | CD53 | I6 | 8.41 | 0% | AC011450.2 CD37 | Ix | 8.10 | 0% | IGHV3-6 | I26 | 7.23 | 49.91% | DUSP22 AL357054.1 | Ix | 7.76 | 0% | PAFAH1B2 | I6 | 7.86 | 0% | HNRNPH1 | I1 | 8.06 | 0% | C11orf48 | I4 | 7.33 | 43.98% | FADS3 | I8 | 7.62 | 0% | MS4A6A | I6 | 8.28 | 0% | DDX5 | I12 | 7.96 | 0% | ANKRD44 | I32 | 7.57 | 0% | AC012652.3 AC012652.5 | Ix | 7.66 | 0% | VPRBP | I28 | 6.94 | 108.65% | IGHV3-6 IGHM | Ix | 7.95 | 269.56% | MS4A6A | I6 | 8.41 | 0% | CD22 | I2 | 8.62 | 0% | PSMB7 | I12 | 8.82 | 100.21% | PTPN1 | I9 | 8.50 | 26.58% | AC096579.1 AC096579.3 | Ix | 8.17 | 0% | CD1C | I5 | 7.94 | 0% | AICDA | I3 | 7.97 | 0% | HLA-A | I4 | 6.95 | 0% | PTPN1 | I9 | 7.28 | 25.24% | PAFAH1B2 | I6 | 8.11 | 0% | FTL | I3 | 7.69 | 0% | SYNE2 | I113 | 7.67 | 0% | MED1 | I17 | 7.70 | 0% | IGHV3-6 | I2 | 7.81 | 0% | CD74 | I8 | 7.29 | 0% |
| 26 | CD53 | I5 | 8.40 | 0% | PTPN1 | I9 | 8.08 | 0% | NXF1 | I10 | 7.22 | 35.26% | NAP1L1 | I13 | 7.74 | 0% | AC012652.3 AC012652.5 | Ix | 7.83 | 0% | AC007620.1 | I1 | 8.03 | 0% | AC016995.1 | I3 | 7.33 | 45711.11% | H2AFX | I1 | 7.57 | 0% | PARP15 | I6 | 8.26 | 0% | AC034193.2 | I1 | 7.89 | 0% | FTL | I3 | 7.56 | 0% | MORN1 | I1 | 7.65 | 0% | RP11-149B7.3 AL136219.3 | Ix | 6.88 | 54.17% | BTNL9 | I11 | 7.87 | 66.55% | NEIL1 | I7 | 8.40 | 0% | ANKRD44 | I32 | 8.60 | 0% | C17orf62 | I3 | 8.80 | 53.49% | SRRM2 | I13 | 8.48 | 25.65% | LRMP | I17 | 8.06 | 0% | TBC1D10C PPP1CA | Ix | 7.93 | 0% | AC007620.1 | I1 | 7.96 | 0% | BAX | I6 | 6.91 | 0% | BTN3A2 | I11 | 7.27 | 122.38% | AP000944.1 | I1 | 8.09 | 0% | HNRNPH1 | I4 | 7.66 | 0% | SLC25A15 | I8 | 7.64 | 0% | P2RX5 | I11 | 7.69 | 0% | ISG20 | I1 | 7.77 | 0% | AC009060.6 | I2 | 7.29 | 0% |
| 27 | MTCH1 | I11 | 8.37 | 0% | C12orf35 | I4 | 8.07 | 0% | PSMB7 | I12 | 7.17 | 34.45% | PMAIP1 | I2 | 7.73 | 0% | RGS2 | I3 | 7.82 | 0% | IL16 | I20 | 8.02 | 0% | FAM65B | I16 | 7.30 | 72.25% | NAPSB | I4 | 7.55 | 0% | DDX5 | I12 | 8.21 | 0% | FNBP1 | I23 | 7.76 | 0% | IGHG2 | I2 | 7.56 | 0% | U2AF1L4 | I8 | 7.55 | 0% | DUSP22 AL357054.1 | Ix | 6.88 | 28.49% | AC107377.1 AC005332.1 | Ix | 7.80 | 75.28% | CD53 | I7 | 8.38 | 0% | NAPSB | I5 | 8.60 | 0% | HNRNPH1 | I1 | 8.78 | 39.34% | HNRNPH1 | I2 | 8.46 | 40.29% | LRMP | I16 | 8.06 | 0% | TIPRL | I8 | 7.92 | 0% | CD83 | I3 | 7.94 | 0% | AC012379.2 SHC4 | Ix | 6.90 | 0% | MED1 | I17 | 7.20 | 83.27% | AP000944.1 | I2 | 8.08 | 0% | CD74 | I4 | 7.61 | 0% | CD22 | I2 | 7.58 | 0% | FTL | I3 | 7.68 | 0% | RPL30 | I3 | 7.77 | 0% | C11orf48 | I4 | 7.28 | 0% |
| 28 | RGS1 | I3 | 8.36 | 0% | HNRNPH1 | I3 | 8.07 | 0% | SYVN1 | I2 | 7.16 | 39.35% | PELI1 AC074289.1 | Ix | 7.72 | 0% | AC007255.2 | I2 | 7.82 | 0% | SGK1 | I19 | 8.01 | 0% | RP11-149B7.3 AL136219.3 | Ix | 7.18 | 56.75% | SUSD2 | I5 | 7.55 | 0% | PAFAH1B2 | I6 | 8.10 | 0% | FTL | I3 | 7.74 | 0% | AC011450.2 CD37 | Ix | 7.54 | 0% | AC009060.6 | I2 | 7.47 | 0% | AC012379.2 SHC4 | Ix | 6.82 | 33.20% | ANKRD44 | I32 | 7.77 | 132.37% | CD1C | I4 | 8.37 | 0% | HNRNPH1 | I1 | 8.59 | 0% | POU2AF1 | I5 | 8.78 | 24.79% | HNRNPH1 | I1 | 8.43 | 39.40% | SAT1 | I2 | 8.03 | 0% | FADS3 | I8 | 7.90 | 0% | DOK3 | I7 | 7.91 | 0% | FAU | I1 | 6.88 | 0% | PDK1 | I15 | 7.18 | 90.12% | SNRPD3 | I4 | 8.05 | 0% | MED1 | I17 | 7.61 | 0% | NDE1 | I11 | 7.58 | 0% | H2AFV | I5 | 7.62 | 0% | AC011450.2 CD37 | Ix | 7.76 | 0% | SNRPD3 | I4 | 7.20 | 0% |
| 29 | FTH1 | I1 | 8.30 | 0% | KHSRP | I20 | 8.07 | 0% | PAFAH1B2 | I6 | 7.10 | 55.06% | ANKRD30B | I6 | 7.70 | 0% | AC018633.1 AVL9 | Ix | 7.74 | 0% | HNRNPH1 | I2 | 8.00 | 0% | HNRNPH1 | I4 | 7.16 | 45.50% | GNB2L1 | I2 | 7.53 | 0% | NAPSB | I5 | 8.07 | 0% | UBE2H | I10 | 7.73 | 0% | AC012379.2 SHC4 | Ix | 7.53 | 0% | BCL2 | I1 | 7.38 | 0% | AC034193.2 | I1 | 6.82 | 253.30% | HNRNPH1 | I1 | 7.70 | 23.85% | SGK1 | I17 | 8.19 | 0% | HNRNPH1 | I2 | 8.56 | 0% | AC016525.1 | I3 | 8.78 | 38.35% | BCL11A | I3 | 8.40 | 189.55% | TEX9 | I12 | 8.00 | 0% | GGA2 | I3 | 7.86 | 0% | HNRNPH1 | I3 | 7.86 | 0% | RP5-857K21.2 | I5 | 6.87 | 0% | PASK | I13 | 7.18 | 77.65% | CLIC5 | I16 | 7.91 | 0% | DEXI | I2 | 7.57 | 0% | AC009060.6 | I2 | 7.55 | 0% | AC009060.6 | I2 | 7.55 | 0% | MKNK2 | I3 | 7.71 | 0% | MED1 | I17 | 7.14 | 0% |
| 30 | ITGAE AC087742.1 | Ix | 8.30 | 0% | CUGBP1 | I15 | 7.98 | 0% | ZC3H11A | I2 | 7.06 | 34.30% | NCRNA00164 | I4 | 7.67 | 0% | MYC | I2 | 7.57 | 0% | P2RX5 | I11 | 7.99 | 0% | BCAT1 | I8 | 7.16 | 381.62% | PIM2 | I3 | 7.53 | 0% | AC007283.2 | I2 | 8.03 | 0% | GNAI2 | I12 | 7.72 | 0% | SYVN1 | I2 | 7.50 | 0% | HNRPDL | I7 | 7.36 | 0% | UBE2H | I10 | 6.78 | 163.45% | ILF3 | I11 | 7.66 | 38.55% | CD1C | I5 | 8.18 | 0% | BTNL9 | I6 | 8.55 | 0% | SNRNP70 | I8 | 8.75 | 44.90% | C17orf62 | I3 | 8.37 | 36.52% | TPT1 | I2 | 7.97 | 0% | PTPRB | I25 | 7.85 | 0% | ZC3HAV1L AC083868.1 | Ix | 7.86 | 0% | CHST11 | I1 | 6.82 | 0% | PCSK7 | I16 | 7.11 | 87.29% | NAP1L1 | I13 | 7.85 | 0% | FAM65B | I16 | 7.54 | 0% | CTCFL | I13 | 7.53 | 0% | ITGAE AC087742.1 | Ix | 7.52 | 0% | RPS2 | I1 | 7.70 | 0% | AC012379.2 SHC4 | Ix | 7.13 | 0% |
| 31 | PFDN5 | I2 | 8.29 | 0% | SFRS6 | I3 | 7.96 | 0% | MORN1 | I1 | 7.02 | 5385.89% | TMSB10 C2orf89 | Ix | 7.65 | 0% | DIMT1L | I11 | 7.57 | 0% | AC012652.3 AC012652.5 | Ix | 7.94 | 0% | SFRS6 | I3 | 7.12 | 27.23% | GNB2L1 | I2 | 7.49 | 0% | C13orf18 | I3 | 8.00 | 0% | AC105446.1 TRIM56 | Ix | 7.68 | 0% | UBE2H | I10 | 7.49 | 0% | AC034193.2 | I1 | 7.30 | 0% | ATP8B1 | I17 | 6.69 | 1167.94% | AC006273.1 C19orf6 | Ix | 7.62 | 37.23% | AC116552.2 CYBA | Ix | 8.15 | 0% | AP000944.1 | I1 | 8.46 | 0% | FUS | I9 | 8.74 | 67.16% | EML6 | I41 | 8.35 | 105.30% | LRMP | I18 | 7.95 | 0% | CNOT7 | I6 | 7.81 | 0% | SFRS5 | I5 | 7.84 | 0% | TSPAN33 | I7 | 6.82 | 0% | COL5A1 | I62 | 7.10 | 54.44% | HLA-A | I4 | 7.84 | 0% | CD1C | I4 | 7.52 | 0% | GNAI2 | I12 | 7.50 | 0% | PAQR3 | I10 | 7.43 | 0% | CD74 | I8 | 7.69 | 0% | APLNR | I1 | 7.06 | 0% |
| 32 | CD53 | I8 | 8.28 | 0% | TROVE2 | I10 | 7.93 | 0% | C11orf48 | I4 | 6.98 | 67.83% | CD53 | I8 | 7.61 | 0% | D87015.1 SC-9C5.1 D86994.3 BCRL4 | Ix | 7.56 | 0% | DOK3 | I7 | 7.91 | 0% | HNRPDL | I7 | 7.10 | 65.37% | CTSH | I5 | 7.42 | 0% | ATP8B1 | I17 | 7.96 | 0% | HNRNPH1 | I3 | 7.64 | 0% | NAP1L1 | I13 | 7.44 | 0% | NAPSB | I4 | 7.29 | 0% | DIMT1L | I11 | 6.66 | 49.34% | EVL | I12 | 7.61 | 22.13% | NEIL1 | I6 | 8.15 | 0% | AC096579.1 AC096579.3 | Ix | 8.44 | 0% | EVL | I12 | 8.73 | 41.09% | CYTH1 | I20 | 8.33 | 93.29% | RGS13 | I3 | 7.95 | 0% | CD22 | I4 | 7.80 | 0% | AP000944.1 | I2 | 7.81 | 0% | PAFAH1B2 | I6 | 6.79 | 0% | AC009060.6 | I2 | 7.09 | 882.43% | SNRNP70 | I8 | 7.77 | 0% | AC034193.2 | I1 | 7.52 | 0% | MKNK2 | I3 | 7.48 | 0% | RP11-367J7.3 | I1 | 7.36 | 0% | NAPSB | I5 | 7.68 | 0% | PTPN1 | I9 | 7.05 | 0% |
| 33 | TMEM49 | I11 | 8.23 | 0% | CSNK2A2 | I11 | 7.87 | 0% | AC105446.1 TRIM56 | Ix | 6.94 | 288.29% | PRDM2 | I14 | 7.61 | 0% | CLPP | I1 | 7.53 | 0% | CHI3L1 | I7 | 7.82 | 0% | AC231380.2 TRBC1 | Ix | 7.01 | 78.71% | RPLP0 | I5 | 7.39 | 0% | NAP1L1 | I13 | 7.95 | 0% | NDE1 | I11 | 7.62 | 0% | HNRNPH1 | I3 | 7.43 | 0% | DDX5 | I12 | 7.28 | 0% | DGKZ | I29 | 6.61 | 83.92% | GNAI2 | I12 | 7.56 | 21.78% | PFDN5 | I2 | 8.14 | 0% | BLK | I10 | 8.44 | 0% | IGHV3-6 IGHM | Ix | 8.68 | 49.91% | DUSP22 AL357054.1 | Ix | 8.33 | 57.48% | AP000944.1 | I2 | 7.95 | 0% | PAFAH1B2 | I6 | 7.72 | 0% | CD74 | I8 | 7.77 | 0% | PLD3 | I3 | 6.76 | 0% | REPIN1 ZNF775 RP4-584D14.2 | Ix | 7.07 | 30.85% | MORN1 | I1 | 7.76 | 0% | BTNL9 | I9 | 7.52 | 0% | RP11-190J1.3 KCNIP2 | Ix | 7.48 | 0% | NDE1 | I11 | 7.36 | 0% | RPL27 | I1 | 7.65 | 0% | RP11-149B7.3 | I1 | 7.04 | 0% |
| 34 | CD74 | I7 | 8.23 | 0% | SNRPD3 | I4 | 7.79 | 0% | CIITA | I19 | 6.93 | 25.48% | CCDC110 | I1 | 7.60 | 0% | COL25A1 | I44 | 7.53 | 0% | AL035670.1 | I1 | 7.80 | 0% | FAIM3 | I3 | 6.86 | 23.65% | PRDM2 | I14 | 7.36 | 0% | AC105446.1 TRIM56 | Ix | 7.94 | 0% | MED1 | I17 | 7.61 | 0% | FNBP1 | I23 | 7.39 | 0% | PAFAH1B2 | I6 | 7.28 | 0% | SIRPB2 | I6 | 6.58 | 252.47% | NXF1 | I10 | 7.55 | 34.40% | ATP8B1 | I17 | 8.13 | 0% | CDK5RAP3 | I7 | 8.43 | 0% | CORO1B | I3 | 8.68 | 126.90% | BLACE | I5 | 8.33 | 56.91% | BUB3 | I7 | 7.94 | 0% | CD74 | I4 | 7.72 | 0% | CR2 | I3 | 7.77 | 0% | TRAF4 | I8 | 6.75 | 0% | COL5A1 | I61 | 7.03 | 51.58% | RGS1 | I3 | 7.75 | 0% | NAPSB | I5 | 7.52 | 0% | SLC25A15 | I8 | 7.44 | 0% | IL16 | I21 | 7.32 | 0% | PFKM | I11 | 7.65 | 0% | AC012652.3 AC012652.5 | Ix | 7.04 | 0% |
| 35 | MS4A1 | I3 | 8.21 | 0% | B2M | I3 | 7.79 | 0% | NDE1 | I11 | 6.93 | 40.70% | AC116552.1 | I2 | 7.57 | 0% | WNK2 | I18 | 7.53 | 0% | AC011450.2 CD37 | Ix | 7.79 | 0% | NDE1 | I11 | 6.86 | 133.28% | CD53 | I7 | 7.35 | 0% | AC096579.3 IGKV3-20 | Ix | 7.90 | 0% | HLA-A | I4 | 7.57 | 0% | NAPSB | I4 | 7.37 | 0% | UBE2H | I10 | 7.27 | 0% | SYVN1 | I2 | 6.55 | 27.05% | C1orf220 RP5-990P15.1 | Ix | 7.55 | 129.88% | C17orf62 | I3 | 8.12 | 0% | SNRNP70 | I8 | 8.42 | 0% | CORO1B | I11 | 8.64 | 123.63% | IGHV3-6 | I25 | 8.29 | 487.90% | FNBP1 | I23 | 7.92 | 0% | TCL1A | I3 | 7.70 | 0% | SGK1 | I17 | 7.75 | 0% | MKNK2 | I3 | 6.69 | 0% | COL5A1 | I63 | 6.96 | 49.28% | AC105446.1 TRIM56 | Ix | 7.70 | 0% | IGHV3-6 | I26 | 7.47 | 0% | BTN3A2 | I11 | 7.38 | 0% | DIMT1L | I11 | 7.32 | 0% | ACADVL | I10 | 7.61 | 0% | ZC3H12D | I6 | 7.01 | 0% |
| 36 | CUGBP1 | I15 | 8.20 | 0% | NAP1L1 | I13 | 7.71 | 0% | AK2 RP1-117O3.1 | Ix | 6.88 | 50.96% | ZNF355P | I1 | 7.55 | 0% | RPL17 | I1 | 7.53 | 0% | TMEM49 | I11 | 7.79 | 0% | KIAA0391 | I1 | 6.85 | 38.63% | C1orf186 | I2 | 7.33 | 0% | HNRNPH1 | I3 | 7.83 | 0% | IL16 | I20 | 7.53 | 0% | AC096579.1 AC096579.3 | Ix | 7.36 | 0% | SFRS5 | I5 | 7.26 | 0% | WDR4 | I11 | 6.53 | 80.89% | LRRC61 | I5 | 7.55 | 157.31% | P2RX5 | I11 | 8.07 | 0% | FAM65B | I16 | 8.35 | 0% | HNRNPH1 | I2 | 8.63 | 35.31% | REL | I7 | 8.19 | 62.32% | HMGB1 | I6 | 7.89 | 0% | PTPRB | I28 | 7.68 | 0% | IGHA2 | I3 | 7.72 | 0% | NAP1L1 | I13 | 6.62 | 0% | IGHV3-6 | I25 | 6.94 | 28.60% | IGHV3-6 IGHM | Ix | 7.69 | 0% | CUGBP1 | I15 | 7.43 | 0% | IGHV3-6 IGHM | Ix | 7.36 | 0% | DOK3 | I7 | 7.30 | 0% | AP000944.1 | I1 | 7.60 | 0% | SFRS5 | I5 | 7.00 | 0% |
| 37 | IGHV3-6 IGHM | Ix | 8.17 | 0% | AC034193.2 | I1 | 7.66 | 0% | SNRPD3 | I4 | 6.88 | 41.65% | RP11-149B7.3 | I1 | 7.55 | 0% | SEPT10 | I15 | 7.50 | 0% | METTL9 | I4 | 7.79 | 0% | PTPN1 | I9 | 6.84 | 25.91% | RPL10A | I1 | 7.33 | 0% | AC012652.3 AC012652.5 | Ix | 7.78 | 0% | B2M | I3 | 7.52 | 0% | ARG2 | I7 | 7.28 | 0% | SFRS6 | I3 | 7.25 | 0% | MBD1 | I18 | 6.39 | 38.17% | HNRNPH1 | I2 | 7.53 | 21.29% | AC012379.2 SHC4 | Ix | 8.06 | 0% | MGEA5 | I12 | 8.33 | 0% | AP1G2 AL135999.3 | Ix | 8.61 | 44.32% | FBP2 | I4 | 8.18 | 61.09% | RP11-149B7.3 | I1 | 7.87 | 0% | TCL6 | I11 | 7.67 | 0% | DUSP22 AL357054.1 | Ix | 7.66 | 0% | RPL30 | I4 | 6.61 | 0% | FAM65B | I16 | 6.92 | 42.71% | PCBP2 | I12 | 7.63 | 0% | SNRPD3 | I4 | 7.41 | 0% | AC007620.1 | I1 | 7.24 | 0% | MICAL2 | I26 | 7.30 | 0% | AC105446.1 TRIM56 | Ix | 7.59 | 0% | TROVE2 | I10 | 6.98 | 0% |
| 38 | CORO1A | I2 | 8.14 | 0% | TIPRL | I8 | 7.63 | 0% | FNBP1 | I23 | 6.87 | 35.44% | HNRNPH1 | I3 | 7.54 | 0% | FEZF1 | I1 | 7.49 | 0% | SFRS3 | I3 | 7.74 | 0% | UNK | I2 | 6.80 | 341.51% | PCBP2 | I12 | 7.30 | 0% | FUS | I9 | 7.77 | 0% | SNRPD3 | I4 | 7.49 | 0% | HNRNPH1 | I2 | 7.28 | 0% | SLC25A15 | I8 | 7.23 | 0% | IGHV3-6 | I20 | 6.37 | 407.83% | RP11-149B7.3 | I1 | 7.48 | 108.02% | TEX9 MNS1 | Ix | 8.06 | 0% | GGA2 | I3 | 8.29 | 0% | MTCH1 | I11 | 8.61 | 95.18% | SYVN1 | I2 | 8.18 | 28.00% | RP11-154D6.1 | I5 | 7.84 | 0% | POU2AF1 | I5 | 7.65 | 0% | AC034193.2 | I1 | 7.64 | 0% | MORN1 | I1 | 6.61 | 0% | C19orf54 | I1 | 6.90 | 78.44% | MYL6 | I6 | 7.60 | 0% | CD1C | I5 | 7.40 | 0% | CSNK2A2 | I11 | 7.20 | 0% | BTN3A2 | I11 | 7.22 | 0% | IGHG1 | I1 | 7.58 | 0% | AP000944.1 | I1 | 6.98 | 0% |
| 39 | TBC1D10C PPP1CA | Ix | 8.12 | 0% | H2AFX | I1 | 7.62 | 0% | KIAA0391 | I1 | 6.87 | 33.98% | HSP90B1 | I13 | 7.54 | 0% | SORBS2 RP11-301L8.1 | Ix | 7.45 | 0% | PAQR3 | I10 | 7.74 | 0% | LYRM2 | I3 | 6.80 | 74.16% | TECR | I10 | 7.29 | 0% | DNAJC16 | I17 | 7.77 | 0% | IGHV3-6 IGHM | Ix | 7.48 | 0% | H2AFV | I5 | 7.27 | 0% | MBD1 | I18 | 7.23 | 0% | AC007283.2 | I2 | 6.37 | 44.58% | FNBP1 | I23 | 7.47 | 43.53% | CD74 | I8 | 8.04 | 0% | CIITA | I19 | 8.28 | 0% | GGA2 | I3 | 8.59 | 52.87% | WEE1 | I6 | 8.14 | 24.42% | RGS1 | I3 | 7.80 | 0% | NAALADL2 | I17 | 7.64 | 0% | OR2I1P | I1 | 7.60 | 0% | RANGRF SLC25A35 | Ix | 6.60 | 0% | AFAP1 | I15 | 6.88 | 275.75% | MICAL2 | I27 | 7.59 | 0% | CD74 | I6 | 7.39 | 0% | AC012379.2 SHC4 | Ix | 7.16 | 0% | CUGBP1 | I15 | 7.20 | 0% | SYNE2 | I114 | 7.58 | 0% | MICAL2 | I27 | 6.98 | 0% |
| 40 | MS4A1 | I5 | 8.11 | 0% | BTN3A2 | I11 | 7.60 | 0% | RASGRF1 | I25 | 6.86 | 89.84% | AC010319.2 | I1 | 7.52 | 0% | SEPT10 | I14 | 7.41 | 0% | SIRPB2 | I6 | 7.71 | 0% | HNRNPH1 | I3 | 6.77 | 34.73% | MORN1 | I1 | 7.28 | 0% | AC096579.1 AC096579.3 | Ix | 7.76 | 0% | AC231380.2 TRBC1 | Ix | 7.48 | 0% | TROVE2 | I10 | 7.26 | 0% | HLA-A | I4 | 7.20 | 0% | AP1S3 | I10 | 6.31 | 104.92% | SFRS6 | I3 | 7.46 | 48.49% | C17orf62 | I5 | 8.02 | 0% | AL645941.2 HLA-DMB HLA-DMA | Ix | 8.26 | 0% | CD1C | I5 | 8.53 | 30.18% | NEIL1 | I2 | 8.13 | 45.10% | AC096579.1 AC096579.3 | Ix | 7.79 | 0% | RP11-149B7.3 | I1 | 7.61 | 0% | DDX5 | I12 | 7.59 | 0% | TYROBP | I2 | 6.58 | 0% | GPR172A | I1 | 6.88 | 46.11% | CASP1 | I13 | 7.55 | 0% | FNBP1 | I23 | 7.38 | 0% | AC016995.1 | I3 | 7.13 | 0% | CNOT7 | I6 | 7.08 | 0% | RPL17 | I1 | 7.56 | 0% | ARHGEF18 | I20 | 6.97 | 0% |
| 41 | RPL27 | I1 | 8.09 | 0% | MED1 | I17 | 7.56 | 0% | ATP8B1 | I18 | 6.85 | 1004.95% | POU2AF1 | I5 | 7.48 | 0% | CUGBP1 | I15 | 7.39 | 0% | CD53 | I6 | 7.71 | 0% | AP000944.1 | I2 | 6.76 | 30.03% | AC007283.2 | I2 | 7.27 | 0% | SRRM2 | I13 | 7.72 | 0% | SFRS6 | I3 | 7.44 | 0% | AC096579.1 AC096579.3 | Ix | 7.24 | 0% | AC012379.2 SHC4 | Ix | 7.19 | 0% | ATP8B1 | I18 | 6.27 | 870.58% | SNRPD3 | I4 | 7.44 | 68.05% | CD22 | I4 | 8.02 | 0% | HNRNPD | I8 | 8.25 | 0% | SFRS6 | I3 | 8.53 | 82.81% | TEX9 | I12 | 8.09 | 101.78% | FUBP1 | I22 | 7.77 | 0% | ANKRD44 | I32 | 7.59 | 0% | TP53 | I4 | 7.56 | 0% | PSME2 | I2 | 6.58 | 0% | AK2 RP1-117O3.1 | Ix | 6.87 | 41.23% | ACADVL | I9 | 7.54 | 0% | CSNK2A2 | I11 | 7.37 | 0% | IL16 | I21 | 7.13 | 0% | DUSP22 AL357054.1 | Ix | 7.04 | 0% | P2RX5 | I11 | 7.45 | 0% | C14orf45 | I18 | 6.97 | 0% |
| 42 | ILF3 | I11 | 8.08 | 0% | AC105446.1 TRIM56 | Ix | 7.55 | 0% | AC007283.2 | I2 | 6.82 | 44.68% | SFRS6 | I3 | 7.47 | 0% | REPIN1 ZNF775 RP4-584D14.2 | Ix | 7.34 | 0% | FAM65B | I16 | 7.64 | 0% | AC012652.3 AC012652.5 | Ix | 6.76 | 90.42% | TCIRG1 | I5 | 7.25 | 0% | SFRS6 | I3 | 7.70 | 0% | ZC3H11A | I2 | 7.42 | 0% | AC231380.2 TRBC1 | Ix | 7.16 | 0% | P2RX5 | I11 | 7.19 | 0% | TIPRL | I8 | 6.26 | 38.46% | TCIRG1 | I5 | 7.44 | 34.70% | KCNH6 LIMD2 | Ix | 8.01 | 0% | MS4A1 | I4 | 8.21 | 0% | AC096579.1 AC096579.3 | Ix | 8.48 | 248.47% | COL5A1 | I64 | 8.07 | 123.35% | KIF22 | I12 | 7.74 | 0% | MKNK2 | I3 | 7.58 | 0% | RP11-149B7.3 AL136219.3 | Ix | 7.53 | 0% | IL32 | I1 | 6.56 | 0% | MORN1 | I1 | 6.84 | 2067.94% | REPIN1 ZNF775 RP4-584D14.2 | Ix | 7.53 | 0% | HTR3A | I6 | 7.36 | 0% | AC105446.1 TRIM56 | Ix | 7.11 | 0% | AL592183.5 | I7 | 7.03 | 0% | MBD1 | I18 | 7.45 | 0% | DOK3 | I7 | 6.95 | 0% |
| 43 | IL16 | I20 | 8.05 | 0% | BAX | I6 | 7.52 | 0% | MED1 | I17 | 6.80 | 89.54% | RPL27 | I1 | 7.42 | 0% | RGS2 | I2 | 7.33 | 0% | CFLAR ALS2CR10 | Ix | 7.64 | 0% | PAFAH1B2 | I6 | 6.75 | 76.66% | IGHG2 | I2 | 7.23 | 0% | DOK3 | I7 | 7.69 | 0% | MBD1 | I18 | 7.38 | 0% | DDX5 | I12 | 7.11 | 0% | MED1 | I17 | 7.16 | 0% | TOP3A | I19 | 6.21 | 82.26% | TSC22D3 | I6 | 7.40 | 33.41% | C11orf48 | I4 | 7.99 | 0% | CD74 | I6 | 8.20 | 0% | NXF1 | I10 | 8.48 | 53.41% | ANKH | I10 | 8.04 | 347.69% | AL645941.2 HLA-DMB HLA-DMA | Ix | 7.73 | 0% | AC011450.2 CD37 | Ix | 7.54 | 0% | AC019117.2 AC019117.3 | Ix | 7.49 | 0% | AC231380.2 TRBC1 | Ix | 6.48 | 0% | CHD8 | I2 | 6.82 | 51.46% | CUGBP1 | I15 | 7.53 | 0% | BTNL9 | I11 | 7.35 | 0% | SYNE2 | I114 | 7.09 | 0% | LRRC61 | I5 | 7.02 | 0% | AC073343.3 PMS2CL | Ix | 7.45 | 0% | DEXI | I2 | 6.95 | 0% |
| 44 | AC016525.1 | I1 | 8.03 | 0% | ANKRD44 | I32 | 7.51 | 0% | MBD1 | I18 | 6.76 | 40.65% | PAFAH1B2 | I6 | 7.40 | 0% | C8orf33 | I1 | 7.32 | 0% | H2AFX | I1 | 7.61 | 0% | RANGRF SLC25A35 | Ix | 6.72 | 43.57% | RPL9 | I1 | 7.21 | 0% | HNRNPD | I8 | 7.63 | 0% | HNRPDL | I7 | 7.37 | 0% | ATP8B1 | I18 | 7.01 | 0% | GNAI2 | I12 | 7.14 | 0% | IL16 | I20 | 6.14 | 30.32% | AC107377.1 AC005332.1 | Ix | 7.40 | 56.83% | NEIL1 | I5 | 7.97 | 0% | AC016525.1 | I1 | 8.18 | 0% | FUS | I8 | 8.46 | 55.42% | OR2I1P | I1 | 8.01 | 125.29% | FANCL | I13 | 7.72 | 0% | SAT1 | I2 | 7.53 | 0% | H2AFV | I5 | 7.48 | 0% | RPS2 | I1 | 6.46 | 0% | PSMB7 | I12 | 6.78 | 31.63% | FTH1 | I2 | 7.50 | 0% | RP11-149B7.3 | I1 | 7.31 | 0% | IL16 | I20 | 7.08 | 0% | LY75 | I2 | 7.02 | 0% | POU2F2 | I14 | 7.45 | 0% | CD83 | I3 | 6.92 | 0% |
| 45 | PKM2 | I9 | 8.03 | 0% | P2RX5 | I11 | 7.51 | 0% | TCIRG1 | I5 | 6.74 | 28.65% | CFLAR | I20 | 7.39 | 0% | SUSD2 | I11 | 7.31 | 0% | RBMX | I8 | 7.60 | 0% | U2AF1L4 | I5 | 6.70 | 150.55% | AC009237.7 | I1 | 7.19 | 0% | AC011450.2 CD37 | Ix | 7.62 | 0% | CSNK2A2 | I11 | 7.36 | 0% | IGHV3-6 | I26 | 7.01 | 0% | AC007620.1 | I1 | 7.12 | 0% | FXR1 | I20 | 6.10 | 25.94% | ACADVL | I10 | 7.38 | 34.74% | SFRS6 | I3 | 7.95 | 0% | HLA-A | I4 | 8.17 | 0% | CDK5RAP3 | I7 | 8.41 | 46.62% | SNRNP70 | I8 | 8.01 | 46.91% | AC034193.2 | I1 | 7.70 | 0% | BTN3A2 | I11 | 7.51 | 0% | THEM5 | I3 | 7.45 | 0% | TCIRG1 | I5 | 6.44 | 0% | RP11-149B7.3 | I1 | 6.78 | 128.01% | HLA-F | I5 | 7.50 | 0% | AP000944.1 | I1 | 7.31 | 0% | FNBP1 | I23 | 7.08 | 0% | C12orf35 | I4 | 7.01 | 0% | UBA1 | I3 | 7.43 | 0% | NDE1 | I11 | 6.89 | 0% |
| 46 | PTPN1 | I9 | 8.02 | 0% | HNRNPH1 | I1 | 7.47 | 0% | AC009060.6 | I2 | 6.69 | 685.57% | MARCH6 | I12 | 7.36 | 0% | SLC25A37 | I2 | 7.29 | 0% | SNRPD3 | I4 | 7.58 | 0% | PARP15 | I6 | 6.70 | 33.26% | CD53 | I6 | 7.18 | 0% | CD53 | I7 | 7.61 | 0% | AP000944.1 | I2 | 7.34 | 0% | NDE1 | I11 | 7.00 | 0% | AC105446.1 | I2 | 7.09 | 0% | RBM15 | I3 | 6.08 | 160.30% | PAFAH1B2 | I6 | 7.38 | 70.13% | AC006273.1 C19orf6 | Ix | 7.89 | 0% | U2AF1L4 | I5 | 8.17 | 0% | AP1G2 AL135999.3 | Ix | 8.37 | 37.46% | WEE1 | I6 | 8.00 | 22.15% | AP000944.1 | I1 | 7.69 | 0% | RPS2 | I1 | 7.51 | 0% | NAP1L1 | I13 | 7.42 | 0% | CUGBP1 | I15 | 6.44 | 0% | ITGAE AC087742.1 | Ix | 6.76 | 250.28% | AC006273.1 C19orf6 | Ix | 7.48 | 0% | IRF8 | I3 | 7.31 | 0% | P2RX5 | I11 | 7.07 | 0% | APLNR | I1 | 7.01 | 0% | AP000944.1 | I2 | 7.41 | 0% | GNRHR2 | I2 | 6.87 | 0% |
| 47 | B2M | I2 | 8.01 | 0% | VPRBP | I28 | 7.46 | 0% | APLNR | I1 | 6.66 | 103.33% | CD53 | I5 | 7.35 | 0% | PSMB7 | I12 | 7.28 | 0% | TMSB4X | I1 | 7.57 | 0% | DDX39 | I7 | 6.67 | 20.34% | POU2F2 | I14 | 7.18 | 0% | RBM15 | I3 | 7.59 | 0% | CD53 | I7 | 7.30 | 0% | ZC3H11A | I2 | 7.00 | 0% | CD74 | I8 | 7.04 | 0% | ITGAE AC087742.1 | Ix | 6.07 | 156.82% | CHD8 | I2 | 7.38 | 62.79% | DOK3 | I7 | 7.89 | 0% | CD53 | I4 | 8.15 | 0% | TYK2 | I18 | 8.36 | 65.95% | BAX | I6 | 7.95 | 38.70% | PFDN5 | I2 | 7.69 | 0% | PARP10 | I7 | 7.50 | 0% | P2RX5 | I11 | 7.42 | 0% | PSMB7 | I12 | 6.42 | 0% | AK2 RP1-117O3.1 | Ix | 6.76 | 38.15% | NXF1 | I10 | 7.48 | 0% | CIITA | I19 | 7.29 | 0% | RP11-262H14.10 | I1 | 7.06 | 0% | IKZF3 | I7 | 6.98 | 0% | PTPRB | I27 | 7.39 | 0% | WAS | I13 | 6.84 | 0% |
| 48 | CPNE5 | I22 | 7.98 | 0% | CD74 | I8 | 7.42 | 0% | AC231380.2 TRBC1 | Ix | 6.64 | 152.88% | HNRNPH1 | I2 | 7.34 | 0% | IGHG1 | I3 | 7.20 | 0% | KLRK1 AC022075.1 | Ix | 7.56 | 0% | SFRS18 | I3 | 6.65 | 189.51% | ILF3 | I11 | 7.15 | 0% | FNBP1 | I23 | 7.58 | 0% | HNRNPH1 | I1 | 7.29 | 0% | IL16 | I20 | 6.96 | 0% | D87015.1 SC-9C5.1 D86994.3 BCRL4 | Ix | 7.04 | 0% | NDE1 | I11 | 6.06 | 67.11% | DGKA | I11 | 7.37 | 21.02% | PCBP2 | I12 | 7.87 | 0% | CORO1A | I2 | 8.13 | 0% | SFRS3 | I3 | 8.32 | 30.09% | AC096579.1 AC096579.3 | Ix | 7.93 | 101.40% | CUGBP1 | I15 | 7.66 | 0% | CPNE5 | I22 | 7.49 | 0% | SNRPD3 | I4 | 7.41 | 0% | GLA RPL36A | Ix | 6.40 | 0% | APLNR | I1 | 6.71 | 114.29% | DOK3 | I7 | 7.48 | 0% | HECW2 | I30 | 7.25 | 0% | TBC1D17 | I3 | 7.02 | 0% | BAX | I6 | 6.97 | 0% | FCRLB | I4 | 7.35 | 0% | HLA-E | I5 | 6.84 | 0% |
| 49 | HLA-F | I5 | 7.98 | 0% | PARP15 | I6 | 7.36 | 0% | SFRS6 | I3 | 6.61 | 27.32% | HNRPDL | I7 | 7.32 | 0% | CCDC65 FKBP11 | Ix | 7.19 | 0% | NFKBIA | I2 | 7.55 | 0% | CENPT | I9 | 6.63 | 95.31% | CD19 | I2 | 7.10 | 0% | H2AFX | I1 | 7.48 | 0% | SHC4 | I4 | 7.29 | 0% | AL645941.2 HLA-DMB HLA-DMA | Ix | 6.96 | 0% | FTL | I3 | 7.04 | 0% | DOK3 | I7 | 6.05 | 96.61% | GGA2 | I3 | 7.35 | 29.02% | SNRNP70 | I8 | 7.83 | 0% | DULLARD | I1 | 8.12 | 0% | CUGBP1 | I15 | 8.30 | 169.40% | WEE1 | I6 | 7.93 | 21.10% | HSP90B1 | I13 | 7.64 | 0% | C11orf48 | I4 | 7.44 | 0% | CREBZF | I1 | 7.41 | 0% | AC007620.1 | I1 | 6.40 | 0% | AC105446.1 TRIM56 | Ix | 6.70 | 286.15% | COL6A2 | I29 | 7.47 | 0% | IGHGP | I4 | 7.24 | 0% | MBD1 | I18 | 7.02 | 0% | ARG2 | I7 | 6.96 | 0% | SYNE2 | I115 | 7.34 | 0% | NAPSB | I5 | 6.84 | 0% |
| 50 | IL16 | I21 | 7.97 | 0% | TMSB4X | I1 | 7.35 | 0% | PRDM2 | I14 | 6.61 | 49.64% | AC024560.3 | I1 | 7.30 | 0% | TMEM41B | I7 | 7.18 | 0% | AC096579.3 | I27 | 7.53 | 0% | RNASEH2C | I1 | 6.58 | 42.63% | HNRPDL | I7 | 7.10 | 0% | MICAL2 | I27 | 7.48 | 0% | PIM2 | I3 | 7.28 | 0% | C16orf72 | I3 | 6.92 | 0% | SRPK2 | I29 | 7.02 | 0% | PAQR3 | I10 | 6.02 | 245.77% | RGS1 | I3 | 7.35 | 26.62% | CDK5RAP3 | I7 | 7.81 | 0% | CUGBP1 | I15 | 8.10 | 0% | BLK | I10 | 8.26 | 35.01% | ILF3 | I11 | 7.90 | 39.46% | RBMX | I9 | 7.64 | 0% | DDX5 | I12 | 7.42 | 0% | SFRS18 | I3 | 7.41 | 0% | RNASEK | I1 | 6.39 | 0% | RECQL5 | I1 | 6.69 | 52.68% | CD74 | I7 | 7.46 | 0% | HNRNPH1 | I3 | 7.22 | 0% | NAP1L1 | I13 | 6.96 | 0% | D87015.1 SC-9C5.1 D86994.3 BCRL4 | Ix | 6.92 | 0% | TRAP1 | I14 | 7.33 | 0% | MMP20 | I5 | 6.78 | 0% |
| 51 | C17orf62 | I3 | 7.94 | 0% | AC007620.1 | I1 | 7.35 | 0% | DGKG | I10 | 6.56 | 36.90% | IL16 | I21 | 7.29 | 0% | PFDN5 | I2 | 7.18 | 0% | SGK1 | I17 | 7.53 | 0% | C17orf90 | I1 | 6.53 | 40.47% | CDK5RAP3 | I7 | 7.09 | 0% | SAT1 | I2 | 7.47 | 0% | PFN1 | I1 | 7.28 | 0% | AC009060.6 | I2 | 6.89 | 0% | AC096579.1 AC096579.3 | Ix | 7.00 | 0% | MORN1 | I1 | 6.02 | 3458.46% | H2AFX | I1 | 7.33 | 73.41% | IL16 | I21 | 7.81 | 0% | AL645941.2 HLA-DMB HLA-DMA | Ix | 8.10 | 0% | IRF9 | I6 | 8.24 | 45.74% | PSMB7 | I12 | 7.88 | 55.46% | USP34 | I78 | 7.64 | 0% | PCBP2 | I12 | 7.41 | 0% | SGK1 | I15 | 7.33 | 0% | SIRPB2 | I6 | 6.32 | 0% | BAX | I6 | 6.66 | 30.46% | LDB1 | I11 | 7.44 | 0% | CTSH | I5 | 7.21 | 0% | AP000944.1 | I1 | 6.95 | 0% | CREBZF | I1 | 6.86 | 0% | POU2AF1 | I5 | 7.29 | 0% | AC105446.1 | I2 | 6.76 | 0% |
| 52 | NAPSB | I5 | 7.94 | 0% | AL035670.1 TDRD6 | Ix | 7.35 | 0% | CSNK2A2 | I11 | 6.55 | 41.84% | GNB2L1 | I2 | 7.25 | 0% | SFRS9 | I3 | 7.18 | 0% | PKM2 | I11 | 7.51 | 0% | METTL3 | I9 | 6.51 | 42.42% | DGKG | I10 | 7.05 | 0% | GNAI2 | I12 | 7.46 | 0% | CD53 | I6 | 7.27 | 0% | C14orf45 | I18 | 6.89 | 0% | ABCG1 | I22 | 7.00 | 0% | FUT11 | I5 | 6.01 | 135.01% | ACIN1 | I10 | 7.31 | 50.16% | H2AFX | I1 | 7.81 | 0% | HLA-E | I5 | 8.08 | 0% | BTN3A2 | I11 | 8.23 | 71.98% | SNED1 AC005237.2 | Ix | 7.87 | 434.79% | AK2 RP1-117O3.1 | Ix | 7.64 | 0% | IGHV3-6 | I26 | 7.39 | 0% | AK2 RP1-117O3.1 | Ix | 7.32 | 0% | NXF1 | I10 | 6.29 | 0% | ARG2 | I7 | 6.54 | 156.02% | CDK5RAP3 | I7 | 7.44 | 0% | IL16 | I20 | 7.17 | 0% | TROVE2 | I10 | 6.94 | 0% | REPIN1 ZNF775 RP4-584D14.2 | Ix | 6.85 | 0% | RP3-512E2.1 BACH2 | Ix | 7.28 | 0% | AC107377.1 AC005332.1 | Ix | 6.71 | 0% |
| 53 | POU2F2 | I14 | 7.91 | 0% | AC007283.2 | I2 | 7.33 | 0% | C17orf90 | I1 | 6.48 | 53.64% | SYVN1 | I2 | 7.25 | 0% | D87015.1 SC-9C5.1 D86994.3 BCRL4 | Ix | 7.18 | 0% | NAPSB | I5 | 7.51 | 0% | IL16 | I20 | 6.51 | 49.73% | KHSRP | I20 | 7.04 | 0% | CD53 | I8 | 7.46 | 0% | APLNR | I1 | 7.22 | 0% | PARP15 | I7 | 6.88 | 0% | CYBASC3 | I3 | 6.99 | 0% | ARG2 | I6 | 6.01 | 116.68% | OSBPL10 | I3 | 7.30 | 56.12% | C17orf62 | I4 | 7.77 | 0% | CDK5RAP3 | I5 | 8.07 | 0% | AC006273.1 C19orf6 | Ix | 8.21 | 37.40% | PAX5 | I5 | 7.87 | 40.55% | SLC25A15 | I8 | 7.62 | 0% | SFRS3 | I3 | 7.39 | 0% | SAT1 | I2 | 7.32 | 0% | GPR172A | I1 | 6.29 | 0% | PCSK7 | I15 | 6.54 | 58.33% | TCIRG1 | I5 | 7.43 | 0% | IL16 | I21 | 7.16 | 0% | ARHGEF18 | I20 | 6.94 | 0% | ANKRD44 | I32 | 6.85 | 0% | C8orf12 FAM167A | Ix | 7.28 | 0% | RPS2 | I1 | 6.66 | 0% |
| 54 | IGHV3-6 IGHM | Ix | 7.89 | 0% | IL16 | I20 | 7.31 | 0% | SNRNP70 | I8 | 6.46 | 25.17% | CD19 | I2 | 7.24 | 0% | IGHV3-6 | I26 | 7.17 | 0% | FUS | I8 | 7.49 | 0% | AC009237.7 | I1 | 6.50 | 237.40% | FTL | I3 | 7.02 | 0% | VPRBP | I28 | 7.44 | 0% | ARG2 | I7 | 7.20 | 0% | HNRNPH1 | I1 | 6.86 | 0% | DIMT1L | I11 | 6.98 | 0% | ZC3HAV1L AC083868.1 | Ix | 5.99 | 283.99% | CSNK2A2 | I11 | 7.25 | 41.32% | CEACAM21 | I1 | 7.76 | 0% | TCTN1 | I15 | 8.04 | 0% | MBD4 | I7 | 8.20 | 46.27% | DULLARD | I1 | 7.85 | 36.18% | AC012379.2 SHC4 | Ix | 7.60 | 0% | TCIRG1 | I15 | 7.36 | 0% | AC105446.1 TRIM56 | Ix | 7.31 | 0% | FAM26F RP1-93H18.2 | Ix | 6.28 | 0% | AC034193.2 | I1 | 6.53 | 167.34% | H2AFX | I1 | 7.43 | 0% | POU2AF1 | I5 | 7.12 | 0% | RRP1 | I3 | 6.93 | 0% | C16orf72 | I3 | 6.85 | 0% | PTPRB | I24 | 7.28 | 0% | LDB1 | I11 | 6.64 | 0% |
| 55 | CFLAR | I20 | 7.89 | 0% | IL16 | I21 | 7.30 | 0% | AC012652.3 AC012652.5 | Ix | 6.44 | 57.90% | SPATA21 | I10 | 7.24 | 0% | RGS1 | I3 | 7.16 | 0% | CSNK2A2 | I11 | 7.48 | 0% | MS4A6A | I6 | 6.50 | 21.43% | SOD2 | I5 | 7.02 | 0% | P2RX5 | I11 | 7.43 | 0% | ATP8B1 | I18 | 7.19 | 0% | RBMX | I9 | 6.85 | 0% | SRRM2 | I13 | 6.97 | 0% | ARG2 | I7 | 5.98 | 114.33% | CDK5RAP3 | I7 | 7.24 | 33.89% | CD22 | I2 | 7.75 | 0% | HLA-F | I5 | 7.99 | 0% | SFRS1 | I3 | 8.19 | 58.24% | SERINC5 | I14 | 7.85 | 144.12% | ANKRD49 | I2 | 7.59 | 0% | AD001527.1 | I1 | 7.34 | 0% | CD83 | I2 | 7.31 | 0% | TMSB10 C2orf89 | Ix | 6.26 | 0% | MICAL2 | I27 | 6.50 | 220.42% | PSMB7 | I12 | 7.43 | 0% | AC012379.2 SHC4 | Ix | 7.10 | 0% | CD74 | I8 | 6.91 | 0% | AC034193.2 | I1 | 6.84 | 0% | AC012652.3 AC012652.5 | Ix | 7.27 | 0% | TIPRL | I8 | 6.63 | 0% |
| 56 | HNRPDL | I7 | 7.89 | 0% | FUBP1 | I22 | 7.30 | 0% | PCSK7 | I16 | 6.43 | 24.75% | PBX4 | I3 | 7.21 | 0% | ATP11B | I34 | 7.13 | 0% | RPL30 | I3 | 7.48 | 0% | P2RX5 | I11 | 6.48 | 22.19% | RPL41 | I1 | 7.00 | 0% | D87015.1 SC-9C5.1 D86994.3 BCRL4 | Ix | 7.39 | 0% | HNRNPH1 | I2 | 7.18 | 0% | TCF4 | I20 | 6.85 | 0% | C17orf62 | I3 | 6.97 | 0% | C19orf54 | I1 | 5.94 | 59.64% | DGKZ | I29 | 7.22 | 70.23% | EVL | I12 | 7.75 | 0% | AC012652.3 AC012652.5 | Ix | 7.97 | 0% | ACADVL | I10 | 8.19 | 61.57% | AC006273.1 C19orf6 | Ix | 7.84 | 39.81% | FUBP1 | I21 | 7.59 | 0% | EMG1 | I7 | 7.33 | 0% | ANKRD44 | I32 | 7.29 | 0% | RP11-262H14.10 | I1 | 6.26 | 0% | IL16 | I20 | 6.49 | 35.34% | AC034193.2 | I1 | 7.41 | 0% | FUS | I9 | 7.09 | 0% | PPAN-P2RY11 PPAN P2RY11 | Ix | 6.85 | 0% | RNF167 | I1 | 6.80 | 0% | SYNE2 | I112 | 7.27 | 0% | CD74 | I4 | 6.63 | 0% |
| 57 | NFKBIA | I2 | 7.88 | 0% | GBP2 | I14 | 7.30 | 0% | RP11-262H14.10 | I1 | 6.43 | 597.83% | IGHV3-6 | I25 | 7.21 | 0% | D87015.1 SC-9C5.1 D86994.3 BCRL4 | Ix | 7.13 | 0% | AC007283.2 | I2 | 7.46 | 0% | TROVE2 | I10 | 6.46 | 168.39% | CD53 | I8 | 6.98 | 0% | FUBP1 | I22 | 7.38 | 0% | VPRBP | I28 | 7.18 | 0% | P2RX5 | I11 | 6.84 | 0% | IGHG2 | I2 | 6.95 | 0% | TFIP11 | I15 | 5.93 | 49.57% | MKNK2 | I3 | 7.20 | 23.55% | HNRNPH1 | I3 | 7.74 | 0% | AC009060.6 | I2 | 7.97 | 0% | HLA-F | I5 | 8.17 | 51.18% | CLEC2D | I8 | 7.79 | 64.79% | FANCL | I12 | 7.59 | 0% | ACADVL | I10 | 7.31 | 0% | SFRS6 | I3 | 7.28 | 0% | RP11-149B7.3 | I1 | 6.22 | 0% | AC107377.1 AC005332.1 | Ix | 6.47 | 70.44% | IRF9 | I6 | 7.39 | 0% | AC073343.3 PMS2CL | Ix | 7.08 | 0% | RP11-149B7.3 | I1 | 6.83 | 0% | SIRPB2 | I6 | 6.75 | 0% | ARHGEF18 | I20 | 7.27 | 0% | FNBP1 | I23 | 6.60 | 0% |
| 58 | AC006273.1 C19orf6 | Ix | 7.87 | 0% | FUS | I9 | 7.30 | 0% | VPRBP | I28 | 6.40 | 36.96% | DDX5 | I12 | 7.17 | 0% | AC007255.2 | I2 | 7.11 | 0% | TROVE2 | I10 | 7.45 | 0% | CNPY2 | I3 | 6.45 | 26.77% | CD53 | I5 | 6.96 | 0% | TIPRL | I8 | 7.38 | 0% | SAT1 | I2 | 7.16 | 0% | AC034193.2 | I1 | 6.84 | 0% | PARP15 | I7 | 6.95 | 0% | ITGAE AC087742.1 | Ix | 5.92 | 140.99% | TROVE2 | I10 | 7.17 | 120.70% | SLC6A16 | I6 | 7.73 | 0% | BTN3A2 | I11 | 7.96 | 0% | ACIN1 | I10 | 8.15 | 63.24% | AC096579.1 AC096579.3 | Ix | 7.79 | 91.79% | HNRNPH1 | I2 | 7.58 | 0% | TBC1D10C PPP1CA | Ix | 7.31 | 0% | SGK1 | I14 | 7.27 | 0% | UBE2H | I10 | 6.18 | 0% | ANKH | I10 | 6.29 | 122.11% | FUS | I9 | 7.39 | 0% | AK2 RP1-117O3.1 | Ix | 7.08 | 0% | FAU | I1 | 6.83 | 0% | LUC7L2 | I12 | 6.73 | 0% | DNAJC4 | I6 | 7.26 | 0% | RP11-154D6.1 | I5 | 6.59 | 0% |
| 59 | BTN3A2 | I11 | 7.85 | 0% | RP11-154D6.1 | I5 | 7.29 | 0% | BTN3A2 | I11 | 6.39 | 90.11% | COL5A1 | I65 | 7.15 | 0% | FANCL | I12 | 7.11 | 0% | MED1 | I17 | 7.44 | 0% | AC005682.2 | I2 | 6.44 | 164.69% | PTPN7 | I8 | 6.94 | 0% | C12orf35 | I4 | 7.32 | 0% | RP11-149B7.3 AL136219.3 | Ix | 7.14 | 0% | BCAT1 | I8 | 6.82 | 0% | AC133435.2 TFDP2 | Ix | 6.94 | 0% | FAM65B | I16 | 5.88 | 68.37% | SGK1 | I19 | 7.17 | 27.93% | CORO1A | I2 | 7.73 | 0% | RBMX | I8 | 7.96 | 0% | ILF3 | I11 | 8.15 | 60.94% | FUS | I9 | 7.79 | 35.23% | HNRNPH1 | I1 | 7.57 | 0% | AC004490.2 OAZ1 | Ix | 7.30 | 0% | HNRPDL | I7 | 7.25 | 0% | HLA-A | I7 | 6.18 | 0% | LRRC61 | I5 | 6.28 | 76.70% | DUSP1 | I2 | 7.37 | 0% | PAQR3 | I10 | 7.07 | 0% | RCSD1 | I1 | 6.81 | 0% | TAF13 | I4 | 6.73 | 0% | CSNK2A2 | I11 | 7.22 | 0% | CD3EAP | I2 | 6.59 | 0% |
| 60 | C1orf186 | I9 | 7.85 | 0% | TMEM49 | I11 | 7.26 | 0% | C10orf2 | I2 | 6.38 | 107.32% | METTL3 | I9 | 7.15 | 0% | UBE2E1 | I5 | 7.11 | 0% | AC016525.1 | I1 | 7.43 | 0% | FANCL | I12 | 6.43 | 86.88% | NAPSB | I7 | 6.90 | 0% | CASP1 | I13 | 7.31 | 0% | H2AFV | I5 | 7.14 | 0% | AC105446.1 TRIM56 | Ix | 6.81 | 0% | ATP8B1 | I18 | 6.93 | 0% | DCLRE1C | I19 | 5.84 | 140.09% | IGHV3-6 | I26 | 7.16 | 193.93% | FUS | I9 | 7.72 | 0% | TMSB4X | I1 | 7.96 | 0% | DEXI | I2 | 8.13 | 910.49% | COL5A1 | I65 | 7.78 | 101.10% | CD53 | I7 | 7.55 | 0% | KCNH6 LIMD2 | Ix | 7.27 | 0% | CIITA | I11 | 7.25 | 0% | DULLARD | I1 | 6.15 | 0% | MICAL2 | I26 | 6.28 | 189.22% | PCSK7 | I15 | 7.37 | 0% | AC105446.1 TRIM56 | Ix | 7.06 | 0% | SLC6A16 | I6 | 6.76 | 0% | TEX9 | I12 | 6.73 | 0% | SOD2 | I5 | 7.20 | 0% | TEX9 | I12 | 6.56 | 0% |
| 61 | TAP1 PSMB9 | Ix | 7.84 | 0% | CD53 | I7 | 7.25 | 0% | CECR7 | I4 | 6.38 | 83.09% | SFRS3 | I3 | 7.10 | 0% | AL049778.1 | I2 | 7.11 | 0% | CD53 | I7 | 7.41 | 0% | SP140 | I3 | 6.43 | 38.17% | SFRS6 | I3 | 6.89 | 0% | RP11-1148L6.1 | I1 | 7.31 | 0% | REPIN1 ZNF775 RP4-584D14.2 | Ix | 7.13 | 0% | SFRS6 | I3 | 6.79 | 0% | HNRNPH1 | I2 | 6.92 | 0% | TAF1D | I6 | 5.83 | 26.46% | SGK1 | I17 | 7.16 | 27.83% | LRMP | I18 | 7.71 | 0% | AC011450.2 CD37 | Ix | 7.96 | 0% | RCSD1 | I1 | 8.12 | 41.71% | ANKH | I9 | 7.77 | 287.51% | SFRS6 | I3 | 7.54 | 0% | MBD1 | I18 | 7.26 | 0% | RP11-119K6.2 HELLS | Ix | 7.24 | 0% | MBD1 | I18 | 6.13 | 0% | AC007283.2 | I2 | 6.25 | 70.36% | CD74 | I4 | 7.35 | 0% | TK1 | I5 | 7.03 | 0% | PAFAH1B2 | I6 | 6.76 | 0% | RP11-262H14.10 | I1 | 6.70 | 0% | HNRNPL | I9 | 7.20 | 0% | DDX5 | I12 | 6.55 | 0% |
| 62 | CD53 | I4 | 7.83 | 0% | RBM15 | I3 | 7.25 | 0% | ACIN1 | I10 | 6.35 | 31.87% | ACADVL | I10 | 7.09 | 0% | AC006027.2 | I2 | 7.11 | 0% | HSP90B1 | I13 | 7.40 | 0% | MTCH1 | I11 | 6.42 | 45.34% | BLNK | I12 | 6.87 | 0% | PCBP2 | I12 | 7.28 | 0% | ATP8B1 | I17 | 7.13 | 0% | CD44 | I10 | 6.79 | 0% | AL645941.2 HLA-DMB HLA-DMA | Ix | 6.90 | 0% | WDR4 | I11 | 5.83 | 49.59% | MED1 | I17 | 7.16 | 87.45% | RANGRF SLC25A35 | Ix | 7.67 | 0% | SAT1 | I2 | 7.95 | 0% | TAP2 | I5 | 8.10 | 55.04% | BCL2 | I1 | 7.77 | 42.91% | HNRNPA1 | I10 | 7.54 | 0% | GNAI2 | I12 | 7.25 | 0% | DULLARD | I1 | 7.21 | 0% | CLPP | I1 | 6.11 | 0% | KHSRP | I20 | 6.25 | 69.42% | MED1 | I17 | 7.34 | 0% | SAT1 | I2 | 7.02 | 0% | SYNE2 | I112 | 6.75 | 0% | TMSB4X | I1 | 6.70 | 0% | FCRLB | I3 | 7.19 | 0% | COL5A1 | I64 | 6.50 | 0% |
| 63 | NADSYN1 | I10 | 7.79 | 0% | FNBP1 | I23 | 7.22 | 0% | AC034193.2 | I1 | 6.34 | 89.31% | SFRS9 | I3 | 7.08 | 0% | SOD2 | I5 | 7.09 | 0% | AL035670.1 TDRD6 | Ix | 7.39 | 0% | ANKRD13A | I9 | 6.39 | 44.20% | ACTG1 | I3 | 6.86 | 0% | AC007620.1 | I1 | 7.28 | 0% | AL645941.2 HLA-DMB HLA-DMA | Ix | 7.09 | 0% | SFRS5 | I5 | 6.78 | 0% | SNRNP70 | I8 | 6.89 | 0% | AP000944.1 | I1 | 5.81 | 48.59% | BTNL9 | I8 | 7.15 | 40.28% | HNRNPD | I8 | 7.67 | 0% | D87015.1 SC-9C5.1 D86994.3 BCRL4 | Ix | 7.94 | 0% | SOD2 | I5 | 8.09 | 141.35% | NBEAL2 | I7 | 7.74 | 26.02% | SFRS1 | I3 | 7.52 | 0% | FAU | I1 | 7.24 | 0% | RPS2 | I1 | 7.21 | 0% | MICAL2 | I27 | 6.10 | 0% | TROVE2 | I10 | 6.21 | 109.67% | MYL6 | I5 | 7.34 | 0% | BTNL9 | I12 | 7.02 | 0% | C17orf62 | I3 | 6.75 | 0% | RP11-1148L6.1 | I1 | 6.69 | 0% | BTN3A2 | I11 | 7.19 | 0% | HNRNPH1 | I4 | 6.50 | 0% |
| 64 | MS4A1 | I1 | 7.77 | 0% | HNRNPH1 | I10 | 7.19 | 0% | KCTD17 | I8 | 6.33 | 93.78% | C11orf83 | I1 | 7.08 | 0% | ATP8B1 | I17 | 7.08 | 0% | EIF4G2 | I20 | 7.38 | 0% | IGHV3-6 | I25 | 6.38 | 37.27% | METTL3 | I8 | 6.86 | 0% | UBE2H | I10 | 7.23 | 0% | TROVE2 | I10 | 7.07 | 0% | FXR1 | I20 | 6.78 | 0% | PIM2 | I3 | 6.89 | 0% | DNAJC4 | I6 | 5.81 | 24.74% | MTCH1 | I11 | 7.15 | 65.34% | UBE2H | I10 | 7.66 | 0% | EVL | I12 | 7.89 | 0% | HNRNPH1 | I10 | 8.04 | 23.45% | TCIRG1 | I5 | 7.73 | 42.68% | SFRS3 | I3 | 7.51 | 0% | IGHD IGHV3-6 | Ix | 7.23 | 0% | IGHV3-6 | I26 | 7.20 | 0% | FAM65B | I16 | 6.09 | 0% | TOP3A | I19 | 6.21 | 65.27% | TP53I11 | I8 | 7.32 | 0% | SGK1 | I19 | 7.02 | 0% | AC107377.1 AC005332.1 | Ix | 6.74 | 0% | SP3 | I7 | 6.68 | 0% | TCIRG1 | I5 | 7.16 | 0% | RP11-1148L6.1 | I1 | 6.49 | 0% |
| 65 | DDX5 | I12 | 7.77 | 0% | TMPO | I4 | 7.16 | 0% | SPINT1 | I1 | 6.32 | 42.05% | ATP8B1 | I17 | 7.07 | 0% | DUSP22 AL357054.1 | Ix | 7.08 | 0% | DULLARD | I1 | 7.38 | 0% | KIF22 | I11 | 6.38 | 41.17% | PAFAH1B2 | I6 | 6.84 | 0% | GNRHR2 | I2 | 7.22 | 0% | RPL30 | I3 | 7.07 | 0% | CYBASC3 | I3 | 6.77 | 0% | TROVE2 | I10 | 6.89 | 0% | SRGAP2 | I20 | 5.77 | 50.32% | ARG2 | I7 | 7.14 | 246.96% | AC087500.1 | I1 | 7.66 | 0% | TCIRG1 | I5 | 7.89 | 0% | ACADVL | I9 | 8.04 | 55.38% | ANKRD44 | I32 | 7.73 | 156.82% | PCBP2 | I12 | 7.51 | 0% | TEX9 | I12 | 7.21 | 0% | FUT11 | I5 | 7.19 | 0% | AC010619.2 | I2 | 6.06 | 0% | IL16 | I21 | 6.20 | 28.75% | CORO1A | I2 | 7.32 | 0% | NXF1 | I10 | 7.00 | 0% | OSBPL10 | I3 | 6.74 | 0% | CDK17 | I16 | 6.61 | 0% | STAT6 | I16 | 7.16 | 0% | CD40 | I4 | 6.47 | 0% |
| 66 | SAT1 | I2 | 7.75 | 0% | PARP15 | I7 | 7.10 | 0% | C14orf45 | I18 | 6.30 | 2658.08% | PTPN1 | I9 | 7.07 | 0% | TROVE2 | I10 | 7.08 | 0% | RP11-149B7.3 AL136219.3 | Ix | 7.38 | 0% | DNAJC16 | I17 | 6.38 | 345.68% | CD74 | I7 | 6.82 | 0% | AC231380.2 TRBC1 | Ix | 7.20 | 0% | C14orf45 | I18 | 7.06 | 0% | AC007283.2 | I2 | 6.76 | 0% | WAS | I13 | 6.86 | 0% | ANKRD11 | I7 | 5.76 | 113.71% | COL5A1 | I64 | 7.09 | 79.93% | TCIRG1 | I5 | 7.65 | 0% | BLK | I9 | 7.87 | 0% | ARHGEF1 | I28 | 8.02 | 24.03% | AC011450.2 | I1 | 7.71 | 86.44% | LL22NC03-80A10.2 | I4 | 7.48 | 0% | RPL41 | I1 | 7.19 | 0% | AC009060.6 | I2 | 7.19 | 0% | DDX5 | I11 | 6.06 | 0% | COL5A1 | I60 | 6.19 | 28.73% | PFDN5 | I2 | 7.32 | 0% | HNRNPH1 | I1 | 7.00 | 0% | TAF13 | I4 | 6.73 | 0% | AC006027.2 | I2 | 6.60 | 0% | ACADVL | I9 | 7.13 | 0% | RP3-475N16.1 CNPY3 | Ix | 6.43 | 0% |
| 67 | HLA-E | I5 | 7.73 | 0% | HLA-DQB1 XXbac-BPG254F23.21 | Ix | 7.06 | 0% | RP11-149B7.3 | I1 | 6.29 | 118.10% | BLK | I8 | 7.07 | 0% | H2AFX | I1 | 7.06 | 0% | TIPRL | I8 | 7.37 | 0% | ACADVL | I10 | 6.30 | 38.39% | HNRNPC | I8 | 6.82 | 0% | BAX | I6 | 7.20 | 0% | U2AF1L4 | I5 | 7.06 | 0% | DUSP22 AL357054.1 | Ix | 6.76 | 0% | POU2F2 | I14 | 6.86 | 0% | TAF13 | I4 | 5.74 | 52.53% | MORN1 | I1 | 7.05 | 3149.05% | POU2F2 | I14 | 7.64 | 0% | HNRNPH1 | I10 | 7.87 | 0% | NADSYN1 | I10 | 8.00 | 61.70% | GNAI2 | I12 | 7.70 | 27.53% | PANK2 | I10 | 7.48 | 0% | C17orf90 | I1 | 7.18 | 0% | RPL30 | I3 | 7.15 | 0% | AC016995.1 | I3 | 6.01 | 0% | NDE1 | I11 | 6.14 | 59.42% | HNRNPH1 | I3 | 7.31 | 0% | SGK1 | I17 | 7.00 | 0% | SLC6A16 | I11 | 6.73 | 0% | AC012379.2 SHC4 | Ix | 6.58 | 0% | NXF1 | I10 | 7.13 | 0% | SFRS6 | I3 | 6.39 | 0% |
| 68 | RPL17 | I1 | 7.72 | 0% | HNRNPD | I8 | 7.06 | 0% | MICAL2 | I27 | 6.27 | 214.41% | EHD3 | I2 | 7.06 | 0% | IGHV3-6 | I25 | 7.03 | 0% | IL16 | I21 | 7.31 | 0% | BCAT1 | I9 | 6.27 | 205.92% | EMG1 | I7 | 6.81 | 0% | HNRNPH1 | I10 | 7.19 | 0% | IGHV3-6 | I25 | 7.06 | 0% | B2M | I3 | 6.74 | 0% | WDR4 | I11 | 6.85 | 0% | GPR172A | I1 | 5.73 | 27.88% | STAT2 | I6 | 7.02 | 46.06% | SGK1 | I18 | 7.64 | 0% | SFRS3 | I3 | 7.84 | 0% | IL16 | I21 | 8.00 | 58.69% | AC016525.1 | I1 | 7.69 | 92.35% | CNOT7 | I6 | 7.48 | 0% | RANGRF SLC25A35 | Ix | 7.17 | 0% | NOL7 | I7 | 7.15 | 0% | UBE2D3 | I1 | 5.99 | 0% | CDK17 | I16 | 6.12 | 82.81% | FAM65B | I16 | 7.29 | 0% | ANKRD44 | I32 | 7.00 | 0% | DULLARD | I1 | 6.73 | 0% | TSPAN33 | I7 | 6.57 | 0% | IGHV3-6 | I2 | 7.13 | 0% | AC096579.1 AC096579.3 | Ix | 6.39 | 0% |
| 69 | HLA-E | I3 | 7.71 | 0% | UBE2H | I10 | 7.03 | 0% | AL133375.1 CUL9 | Ix | 6.27 | 120.22% | HNRNPH1 | I1 | 7.05 | 0% | TIPRL | I8 | 7.01 | 0% | ARG2 | I7 | 7.31 | 0% | RBMX | I8 | 6.26 | 24.53% | IGHA2 | I3 | 6.81 | 0% | CD74 | I7 | 7.17 | 0% | PSMB7 | I12 | 7.03 | 0% | H2AFX | I1 | 6.68 | 0% | SLC25A15 | I8 | 6.83 | 0% | TBCE | I18 | 5.71 | 48.22% | CDK5RAP3 | I5 | 7.01 | 28.83% | FCRL5 | I10 | 7.64 | 0% | D87015.1 SC-9C5.1 D86994.3 BCRL4 | Ix | 7.84 | 0% | KHSRP | I20 | 7.98 | 72.21% | SFRS1 | I3 | 7.63 | 35.96% | HNRNPL | I9 | 7.46 | 0% | AP000944.1 | I1 | 7.16 | 0% | TIPRL | I8 | 7.14 | 0% | HLA-DOB | I3 | 5.98 | 0% | TFIP11 | I15 | 6.12 | 37.57% | SFRS6 | I3 | 7.28 | 0% | ZFP36L1 | I1 | 6.98 | 0% | RRP1 | I4 | 6.72 | 0% | ATP8B1 | I18 | 6.57 | 0% | TP53BP1 | I32 | 7.12 | 0% | IGHV3-6 IGHM | Ix | 6.39 | 0% |
| 70 | C11orf48 | I4 | 7.71 | 0% | TEX9 | I12 | 7.03 | 0% | CFLAR | I20 | 6.24 | 21.72% | RNF167 | I1 | 7.04 | 0% | RPL30 | I3 | 7.00 | 0% | ACADVL | I9 | 7.29 | 0% | SNRPD3 | I4 | 6.25 | 23.18% | CUGBP1 | I15 | 6.79 | 0% | MTCH1 | I11 | 7.17 | 0% | IGHV3-6 | I26 | 7.00 | 0% | GNAI2 | I12 | 6.63 | 0% | CDK5RAP3 | I7 | 6.81 | 0% | AC073343.3 PMS2CL | Ix | 5.71 | 8160.10% | FUS | I9 | 7.00 | 35.84% | CD74 | I7 | 7.63 | 0% | PTK2B | I30 | 7.83 | 0% | D87015.1 SC-9C5.1 D86994.3 BCRL4 | Ix | 7.98 | 263.92% | FUS | I8 | 7.59 | 30.83% | SFRS11 | I4 | 7.45 | 0% | RPL30 | I4 | 7.16 | 0% | SFRS3 | I3 | 7.13 | 0% | EMG1 | I7 | 5.98 | 0% | WNK2 | I18 | 6.12 | 254.22% | HLA-E | I3 | 7.24 | 0% | PAFAH1B2 | I6 | 6.98 | 0% | ITGAE AC087742.1 | Ix | 6.71 | 0% | AC105446.1 TRIM56 | Ix | 6.57 | 0% | ARG2 | I7 | 7.12 | 0% | MORN1 | I1 | 6.38 | 0% |
| 71 | AC096579.1 AC096579.3 | Ix | 7.68 | 0% | SH3BP5 AC087590.3 | Ix | 7.02 | 0% | CHD8 | I2 | 6.20 | 39.67% | AP000944.1 | I2 | 7.01 | 0% | IGHV3-6 IGHM | Ix | 6.97 | 0% | AC093520.1 ITGAX | Ix | 7.29 | 0% | IGHV3-6 | I24 | 6.24 | 33.73% | RPL30 | I3 | 6.78 | 0% | SNRNP70 | I8 | 7.16 | 0% | DULLARD | I1 | 7.00 | 0% | FUS | I8 | 6.63 | 0% | D86994.3 | I1 | 6.80 | 0% | DBF4B | I12 | 5.68 | 279.09% | FNBP4 | I11 | 7.00 | 42.65% | TPT1 | I2 | 7.61 | 0% | CLEC2D | I8 | 7.82 | 0% | CREBL1 | I16 | 7.98 | 35.54% | COL5A1 | I62 | 7.59 | 88.73% | ANKRD10 | I7 | 7.45 | 0% | SFRS3 | I4 | 7.15 | 0% | AC011450.2 CD37 | Ix | 7.13 | 0% | THEM5 | I3 | 5.96 | 0% | AC073343.3 PMS2CL | Ix | 6.12 | 4359.71% | RP11-149B7.3 | I1 | 7.24 | 0% | NDE1 | I11 | 6.96 | 0% | MED1 | I17 | 6.69 | 0% | TUG1 MTMR3 | Ix | 6.55 | 0% | ILF3 | I11 | 7.11 | 0% | C16orf72 | I3 | 6.37 | 0% |
| 72 | FTH1 | I2 | 7.67 | 0% | HSP90B1 | I13 | 7.01 | 0% | IGHV3-6 | I25 | 6.20 | 24.16% | ORMDL1 | I1 | 7.01 | 0% | AC034193.2 | I1 | 6.96 | 0% | PKM2 | I10 | 7.27 | 0% | TAF13 | I4 | 6.24 | 48.95% | IGHG2 | I3 | 6.78 | 0% | PSMA3 | I7 | 7.15 | 0% | FUS | I9 | 6.99 | 0% | ATP8B1 | I17 | 6.62 | 0% | ATP8B1 | I17 | 6.80 | 0% | LUC7L2 | I12 | 5.68 | 25.64% | AC105446.1 TRIM56 | Ix | 6.99 | 355.85% | AC016995.1 | I3 | 7.59 | 0% | C17orf62 | I3 | 7.80 | 0% | TMC6 TMC8 | Ix | 7.95 | 32.38% | DENND2D | I9 | 7.58 | 31.01% | SNHG6 | I3 | 7.44 | 0% | PDK1 | I15 | 7.14 | 0% | SMARCA2 | I8 | 7.12 | 0% | SFRS9 | I3 | 5.95 | 0% | DGKZ | I29 | 6.11 | 60.22% | HNRNPD | I8 | 7.21 | 0% | HLA-DPB1 | I3 | 6.96 | 0% | DGKZ | I29 | 6.68 | 0% | RBMX | I9 | 6.54 | 0% | CD74 | I7 | 7.11 | 0% | CTCFL | I13 | 6.35 | 0% |
| 73 | HNRNPH1 | I4 | 7.66 | 0% | CD53 | I8 | 7.01 | 0% | PARP15 | I7 | 6.18 | 26.89% | IL16 | I20 | 7.01 | 0% | D87015.1 SC-9C5.1 D86994.3 BCRL4 | Ix | 6.95 | 0% | C17orf62 | I3 | 7.27 | 0% | EIF2AK4 | I37 | 6.24 | 97.10% | U2AF1L4 | I5 | 6.77 | 0% | FUS | I8 | 7.15 | 0% | AK2 RP1-117O3.1 | Ix | 6.99 | 0% | HNRPDL | I7 | 6.62 | 0% | LRRC61 | I5 | 6.78 | 0% | TP53BP1 | I30 | 5.68 | 59.24% | EML6 | I41 | 6.98 | 57.47% | HNRNPH1 | I10 | 7.56 | 0% | SRRM2 | I9 | 7.79 | 0% | TAPBP | I5 | 7.95 | 29.34% | DENND3 | I16 | 7.56 | 25.08% | HSPD1 | I6 | 7.40 | 0% | MYL6 | I6 | 7.14 | 0% | PAQR3 | I10 | 7.11 | 0% | HLA-DOB | I4 | 5.95 | 0% | ANKH | I9 | 6.10 | 106.62% | CYR61 | I2 | 7.21 | 0% | SEPT1 | I7 | 6.95 | 0% | AC011450.2 CD37 | Ix | 6.68 | 0% | PASK | I13 | 6.53 | 0% | EML6 | I41 | 7.11 | 0% | DIMT1L | I11 | 6.35 | 0% |
| 74 | P2RX5 | I11 | 7.65 | 0% | HNRNPH1 | I2 | 7.01 | 0% | DGKZ | I29 | 6.14 | 35.94% | ITGAE AC087742.1 | Ix | 7.01 | 0% | ILF3 | I11 | 6.94 | 0% | SFRS11 | I4 | 7.27 | 0% | DOK3 | I7 | 6.23 | 130.31% | SPIB | I4 | 6.75 | 0% | PTPN1 | I9 | 7.15 | 0% | AC007283.2 | I2 | 6.98 | 0% | AP000944.1 | I1 | 6.61 | 0% | CD53 | I7 | 6.77 | 0% | CREBZF | I1 | 5.66 | 104.13% | PDK1 | I15 | 6.95 | 80.32% | AC096579.1 AC096579.3 | Ix | 7.56 | 0% | DMTF1 | I21 | 7.77 | 0% | CDK5RAP3 | I5 | 7.94 | 33.78% | SAT1 | I2 | 7.56 | 23.46% | NOL7 | I7 | 7.40 | 0% | C17orf62 | I3 | 7.14 | 0% | TROVE2 | I10 | 7.10 | 0% | TIPRL | I8 | 5.95 | 0% | AC107377.1 AC005332.1 | Ix | 6.09 | 53.92% | FTH1 | I1 | 7.20 | 0% | SFRS6 | I3 | 6.95 | 0% | AC004971.1 | I1 | 6.68 | 0% | ITGAE AC087742.1 | Ix | 6.51 | 0% | CD74 | I4 | 7.09 | 0% | SIRPB2 | I6 | 6.35 | 0% |
| 75 | IGHV3-6 | I26 | 7.64 | 0% | MS4A1 | I4 | 6.98 | 0% | IGHV3-6 | I25 | 6.12 | 22.87% | ATP8B1 | I18 | 6.98 | 0% | CERKL | I18 | 6.93 | 0% | BAX | I6 | 7.26 | 0% | FUBP1 | I22 | 6.23 | 49.58% | REPIN1 ZNF775 RP4-584D14.2 | Ix | 6.74 | 0% | ANKRD10 | I9 | 7.14 | 0% | FUS | I8 | 6.97 | 0% | METTL9 | I4 | 6.58 | 0% | VPRBP | I28 | 6.74 | 0% | KCNC3 | I6 | 5.66 | 50.37% | BTNL9 | I12 | 6.95 | 34.93% | PSMB7 | I12 | 7.54 | 0% | AC096579.1 AC096579.3 | Ix | 7.76 | 0% | FAM65B | I16 | 7.94 | 44.58% | DENND3 | I15 | 7.55 | 24.84% | KIF22 | I11 | 7.39 | 0% | STAT2 | I6 | 7.14 | 0% | C17orf62 | I3 | 7.08 | 0% | U2AF1L4 | I5 | 5.94 | 0% | ZNF588 | I3 | 6.08 | 80.01% | CD53 | I8 | 7.19 | 0% | GNAI2 | I12 | 6.95 | 0% | TOP3A | I19 | 6.68 | 0% | AC016065.1 | I1 | 6.50 | 0% | TBC1D10C PPP1CA | Ix | 7.07 | 0% | ARG2 | I7 | 6.35 | 0% |
| 76 | CDK5RAP3 | I7 | 7.64 | 0% | NDE1 | I11 | 6.98 | 0% | AC007620.1 | I1 | 6.10 | 124.95% | BUB3 | I7 | 6.97 | 0% | CU459211.2 | I8 | 6.92 | 0% | CD53 | I8 | 7.25 | 0% | CRBN | I7 | 6.21 | 26.93% | HNRNPH1 | I4 | 6.74 | 0% | CCDC65 FKBP11 | Ix | 7.10 | 0% | CD22 | I2 | 6.97 | 0% | IL16 | I21 | 6.58 | 0% | NXF1 | I10 | 6.72 | 0% | RANGRF SLC25A35 | Ix | 5.65 | 44.92% | DENND2D | I9 | 6.94 | 25.57% | AC034193.2 | I1 | 7.54 | 0% | TCTN1 | I14 | 7.76 | 0% | OR2I1P | I1 | 7.92 | 131.58% | ACADVL | I10 | 7.54 | 39.53% | RP11-149B7.3 AL136219.3 | Ix | 7.38 | 0% | SFRS18 | I3 | 7.13 | 0% | AC107377.1 AC005332.1 | Ix | 7.06 | 0% | DNAJC4 | I6 | 5.93 | 0% | C16orf72 | I3 | 6.07 | 77.54% | AC107377.1 AC005332.1 | Ix | 7.17 | 0% | IGHG2 | I3 | 6.93 | 0% | AC073343.3 PMS2CL | Ix | 6.65 | 0% | VPRBP | I28 | 6.49 | 0% | TP53BP1 | I30 | 7.06 | 0% | CSNK2A2 | I11 | 6.34 | 0% |
| 77 | AP006284.2 | I1 | 7.63 | 0% | FUS | I8 | 6.98 | 0% | AC006273.1 C19orf6 | Ix | 6.09 | 20.45% | LYRM2 | I3 | 6.94 | 0% | HSP90B1 | I13 | 6.87 | 0% | RGS1 | I3 | 7.25 | 0% | HNRNPH1 | I2 | 6.21 | 23.34% | SFTPB | I12 | 6.73 | 0% | ANKRD10 RP11-120J20.2 | Ix | 7.10 | 0% | AC007620.1 | I1 | 6.94 | 0% | RPS9 LILRA6 LILRB3 | Ix | 6.57 | 0% | TMEM111 AC034193.4 | Ix | 6.70 | 0% | RP11-405L18.3 | I2 | 5.62 | 81.74% | IRF9 | I6 | 6.94 | 30.92% | KHSRP | I20 | 7.52 | 0% | HLA-DPB1 | I2 | 7.75 | 0% | LDB1 | I11 | 7.92 | 71.35% | LY75 | I2 | 7.54 | 27.93% | NDE1 | I11 | 7.37 | 0% | RPS20 | I1 | 7.11 | 0% | CSNK2A2 | I11 | 7.05 | 0% | TSPAN17 | I7 | 5.92 | 0% | C20orf11 | I6 | 6.05 | 25.82% | TMSB4X | I1 | 7.17 | 0% | AP000944.1 | I2 | 6.89 | 0% | SFRS5 | I5 | 6.63 | 0% | SFRS9 | I3 | 6.49 | 0% | MORN1 | I1 | 7.05 | 0% | SH2B2 | I13 | 6.34 | 0% |
| 78 | CORO1B | I11 | 7.63 | 0% | LL22NC03-80A10.2 | I4 | 6.97 | 0% | ANKRD44 | I32 | 6.09 | 84.94% | PTPRB | I26 | 6.94 | 0% | UBE2H | I10 | 6.86 | 0% | SFRS18 | I3 | 7.24 | 0% | AK2 RP1-117O3.1 | Ix | 6.19 | 25.02% | DDX39 | I7 | 6.72 | 0% | ANKDD1A | I17 | 7.10 | 0% | RBMX | I8 | 6.94 | 0% | HSP90B1 | I13 | 6.56 | 0% | CREBZF | I1 | 6.70 | 0% | SATL1 | I5 | 5.61 | 563.73% | LDB1 | I11 | 6.91 | 31.70% | FUBP1 | I22 | 7.51 | 0% | SFRS6 | I3 | 7.75 | 0% | SF1 | I5 | 7.91 | 38.57% | NXF1 | I10 | 7.54 | 40.68% | CLEC2D | I8 | 7.36 | 0% | AC003092.2 | I5 | 7.11 | 0% | AC019117.2 AC019117.3 | Ix | 7.04 | 0% | C19orf54 | I1 | 5.91 | 0% | PI16 | I6 | 6.03 | 26.14% | EHBP1L1 | I16 | 7.15 | 0% | DOK3 | I7 | 6.88 | 0% | SYNE2 | I115 | 6.63 | 0% | AC005037.5 AC005037.9 | Ix | 6.46 | 0% | DDX5 | I11 | 7.05 | 0% | PCBP2 | I12 | 6.31 | 0% |
| 79 | H2AFX | I1 | 7.63 | 0% | SFRS3 | I3 | 6.96 | 0% | ARHGEF18 | I20 | 6.07 | 50.99% | UQCRB | I3 | 6.93 | 0% | FXR1 | I20 | 6.86 | 0% | FCRL5 | I10 | 7.21 | 0% | PRDM2 | I14 | 6.19 | 75.25% | IRF9 | I6 | 6.71 | 0% | TMSB4X | I1 | 7.09 | 0% | DOK3 | I7 | 6.93 | 0% | MBD1 | I18 | 6.56 | 0% | DGKG | I10 | 6.70 | 0% | C16orf7 | I3 | 5.59 | 255.86% | PTPRB | I27 | 6.91 | 701.07% | SEPT6 | I14 | 7.49 | 0% | CD22 | I1 | 7.72 | 0% | TCIRG1 | I5 | 7.91 | 41.61% | AK2 RP1-117O3.1 | Ix | 7.53 | 148.05% | RPLP0 | I5 | 7.36 | 0% | DDX39 | I7 | 7.11 | 0% | FXR1 | I20 | 7.03 | 0% | CORO1A | I2 | 5.90 | 0% | PTPRB | I27 | 6.01 | 323.97% | SFRS9 | I3 | 7.14 | 0% | AL645941.2 HLA-DMB HLA-DMA | Ix | 6.87 | 0% | FBXL18 AC092171.3 | Ix | 6.61 | 0% | ARG2 | I6 | 6.46 | 0% | SFRS9 | I3 | 7.05 | 0% | RP3-475N16.1 CNPY3 | Ix | 6.30 | 0% |
| 80 | LDB1 | I11 | 7.62 | 0% | GNAI2 | I12 | 6.94 | 0% | AC107377.1 AC005332.1 | Ix | 6.04 | 93.01% | NAPSB | I5 | 6.93 | 0% | PDLIM3 | I6 | 6.86 | 0% | CDC42SE1 | I3 | 7.20 | 0% | NUDT13 | I7 | 6.18 | 334.74% | AC012652.3 AC012652.5 | Ix | 6.70 | 0% | NDE1 | I11 | 7.09 | 0% | SRRM2 | I9 | 6.93 | 0% | PNOC | I3 | 6.55 | 0% | AC107377.1 AC005332.1 | Ix | 6.68 | 0% | SIGLEC6 | I9 | 5.55 | 151.54% | AK2 RP1-117O3.1 | Ix | 6.91 | 114.01% | RPL27 | I1 | 7.47 | 0% | ACADVL | I10 | 7.72 | 0% | TAP1 PSMB9 | Ix | 7.90 | 33.86% | UBE2H | I10 | 7.53 | 102.00% | ILF3 | I11 | 7.35 | 0% | ITGAE AC087742.1 | Ix | 7.10 | 0% | GNAI2 | I12 | 7.03 | 0% | ARG2 | I7 | 5.88 | 0% | RP11-560A15.1 | I1 | 6.00 | 1504.10% | AC116552.2 CYBA | Ix | 7.14 | 0% | HTR3A | I5 | 6.85 | 0% | CD22 | I12 | 6.61 | 0% | SLC25A15 | I8 | 6.42 | 0% | AC107377.1 AC005332.1 | Ix | 7.05 | 0% | SFRS9 | I3 | 6.28 | 0% |
| 81 | NFKBIA | I3 | 7.61 | 0% | IGHV3-6 | I25 | 6.94 | 0% | MON1B | I1 | 6.02 | 40.02% | ISG20 | I1 | 6.93 | 0% | GLIPR1 | I5 | 6.86 | 0% | AC009060.6 | I2 | 7.17 | 0% | STIM2 | I2 | 6.18 | 84.86% | PTPRB | I27 | 6.69 | 0% | C10orf104 | I4 | 7.08 | 0% | PSMA3 | I7 | 6.91 | 0% | IGHV3-6 IGHM | Ix | 6.54 | 0% | AC010619.2 | I2 | 6.68 | 0% | C1orf228 | I9 | 5.54 | 29.09% | CDK17 | I16 | 6.90 | 74.09% | CD53 | I6 | 7.46 | 0% | CTSH | I5 | 7.71 | 0% | SEPT1 | I7 | 7.90 | 24.38% | KCNH6 LIMD2 | Ix | 7.53 | 27.85% | CD53 | I6 | 7.33 | 0% | OVCH1 | I17 | 7.10 | 0% | ZC3HAV1L AC083868.1 | Ix | 7.02 | 0% | CASP1 | I13 | 5.84 | 0% | MBD1 | I18 | 5.97 | 44.53% | CDK5RAP3 | I5 | 7.13 | 0% | FUS | I8 | 6.82 | 0% | FBXL18 | I6 | 6.56 | 0% | AC107377.1 AC005332.1 | Ix | 6.39 | 0% | PFDN5 | I2 | 7.04 | 0% | D87015.1 SC-9C5.1 D86994.3 BCRL4 | Ix | 6.28 | 0% |
| 82 | HTR3A | I6 | 7.61 | 0% | CREBZF | I1 | 6.92 | 0% | TFIP11 | I15 | 6.01 | 40.81% | TBC1D27 | I2 | 6.93 | 0% | SLC25A15 | I8 | 6.85 | 0% | CD53 | I5 | 7.17 | 0% | FNBP1 | I23 | 6.14 | 67.20% | PCBP2 | I11 | 6.68 | 0% | HSP90B1 | I13 | 7.06 | 0% | BAX | I6 | 6.91 | 0% | RPL30 | I3 | 6.53 | 0% | HNRNPH1 | I1 | 6.67 | 0% | HSD17B1 | I2 | 5.53 | 301.36% | DUSP1 | I2 | 6.88 | 65.61% | TYK2 | I18 | 7.46 | 0% | CD22 | I12 | 7.71 | 0% | AC012652.3 AC012652.5 | Ix | 7.89 | 166.38% | COL5A1 | I63 | 7.53 | 84.57% | SLC25A15 | I8 | 7.33 | 0% | TRIM5 TRIM22 | Ix | 7.10 | 0% | CNOT7 | I6 | 7.01 | 0% | GSTK1 AC073342.4 | Ix | 5.84 | 0% | ANKRD44 | I32 | 5.96 | 118.34% | GNRHR2 | I2 | 7.13 | 0% | EVL | I12 | 6.82 | 0% | CCL2 | I2 | 6.56 | 0% | TFIP11 | I15 | 6.39 | 0% | CORO1A | I2 | 7.02 | 0% | AP000944.1 | I2 | 6.28 | 0% |
| 83 | C1orf186 | I2 | 7.60 | 0% | TAP1 PSMB9 | Ix | 6.92 | 0% | AC133435.2 TFDP2 | Ix | 6.01 | 100.60% | TCIRG1 | I5 | 6.93 | 0% | RPL27A | I1 | 6.85 | 0% | RP11-154D6.1 | I5 | 7.16 | 0% | IGHV3-6 | I26 | 6.14 | 31.32% | SIGLEC12 | I17 | 6.68 | 0% | RP11-149B7.3 | I1 | 7.04 | 0% | ANKRD44 | I32 | 6.89 | 0% | PIM2 | I3 | 6.50 | 0% | AK2 RP1-117O3.1 | Ix | 6.63 | 0% | RP11-613M10.1 | I1 | 5.52 | 108.71% | COL5A1 | I65 | 6.88 | 68.77% | C10orf104 | I4 | 7.46 | 0% | SOD2 | I5 | 7.70 | 0% | ANKRD44 | I32 | 7.89 | 179.89% | NDE1 | I11 | 7.51 | 77.24% | AK2 RP1-117O3.1 | Ix | 7.32 | 0% | NXF1 | I10 | 7.10 | 0% | FCF1 | I1 | 7.00 | 0% | CCL2 | I2 | 5.83 | 0% | RP11-1148L6.1 | I1 | 5.96 | 96.50% | FUT11 | I5 | 7.11 | 0% | HNRNPH1 | I2 | 6.81 | 0% | NXF1 | I10 | 6.52 | 0% | MCART1 | I3 | 6.38 | 0% | AC023055.2 | I4 | 7.01 | 0% | IRF9 | I6 | 6.27 | 0% |
| 84 | SEPT6 | I12 | 7.59 | 0% | HNRNPA1 | I10 | 6.91 | 0% | MICAL2 | I26 | 5.99 | 176.47% | PRDM2 | I13 | 6.91 | 0% | SORBS2 RP11-301L8.1 | Ix | 6.84 | 0% | FUS | I9 | 7.16 | 0% | AC009060.6 | I2 | 6.13 | 702.59% | SFRS9 | I3 | 6.66 | 0% | B2M | I3 | 7.04 | 0% | SFRS3 | I3 | 6.89 | 0% | BCL2 | I1 | 6.49 | 0% | NAP1L1 | I13 | 6.63 | 0% | C16orf72 | I3 | 5.51 | 63.15% | SFRS1 | I3 | 6.85 | 30.08% | RP11-479I1.1 EIF2S3 | Ix | 7.46 | 0% | BAT1 ATP6V1G2 | Ix | 7.69 | 0% | TMC6 | I2 | 7.86 | 30.30% | RBM25 | I9 | 7.48 | 46.84% | VPRBP | I28 | 7.32 | 0% | IGHV3-6 IGHM | Ix | 7.10 | 0% | B2M | I3 | 6.99 | 0% | REPIN1 ZNF775 RP4-584D14.2 | Ix | 5.81 | 0% | U2AF1L4 | I5 | 5.95 | 133.40% | RP11-1148L6.1 | I1 | 7.11 | 0% | AC231380.2 TRBC1 | Ix | 6.80 | 0% | C20orf11 | I6 | 6.52 | 0% | FUT11 | I5 | 6.36 | 0% | AC096579.3 | I1 | 7.00 | 0% | CNPY3 | I6 | 6.26 | 0% |
| 85 | AL645941.2 HLA-DMB HLA-DMA | Ix | 7.59 | 0% | C17orf62 | I3 | 6.91 | 0% | ANKRD11 | I7 | 5.99 | 68.45% | COL5A1 | I64 | 6.90 | 0% | PABPC1 | I2 | 6.82 | 0% | AC034193.2 | I1 | 7.16 | 0% | TAF1D | I6 | 6.11 | 25.84% | AC004086.1 | I5 | 6.65 | 0% | SNRPD3 | I4 | 7.03 | 0% | CD53 | I8 | 6.88 | 0% | PAQR3 | I10 | 6.48 | 0% | CD74 | I4 | 6.63 | 0% | RP11-1148L6.1 | I1 | 5.51 | 131.06% | C1orf220 RP5-990P15.1 | Ix | 6.85 | 79.39% | CTSH | I9 | 7.45 | 0% | D87015.1 SC-9C5.1 D86994.3 BCRL4 | Ix | 7.68 | 0% | AP000944.1 | I2 | 7.83 | 23.86% | RP11-479I1.1 EIF2S3 | Ix | 7.48 | 25.06% | ANKRD10 | I8 | 7.32 | 0% | C7orf44 STK17A | Ix | 7.09 | 0% | VPRBP | I28 | 6.97 | 0% | CHIT1 | I16 | 5.81 | 0% | CHST11 | I1 | 5.95 | 33.25% | IGHV3-6 | I26 | 7.10 | 0% | AC096579.1 AC096579.3 | Ix | 6.79 | 0% | FAM65B | I16 | 6.51 | 0% | SNX12 | I4 | 6.35 | 0% | RP11-1148L6.1 | I1 | 6.99 | 0% | DNAJC16 | I17 | 6.25 | 0% |
| 86 | AC010619.2 | I2 | 7.58 | 0% | IGHV3-6 | I26 | 6.91 | 0% | PRPF40B | I18 | 5.96 | 409.00% | AC022413.4 | I1 | 6.90 | 0% | FANCL | I13 | 6.80 | 0% | PSMB7 | I12 | 7.16 | 0% | C2orf42 TIA1 | Ix | 6.10 | 38.32% | C5orf45 | I7 | 6.65 | 0% | MED1 | I17 | 7.03 | 0% | PARP15 | I7 | 6.88 | 0% | ZNF418 AC010522.1 | Ix | 6.48 | 0% | FNBP1 | I23 | 6.62 | 0% | TMEM140 C7orf49 | Ix | 5.49 | 49.99% | FUS | I8 | 6.84 | 32.04% | DNAJC16 | I17 | 7.44 | 0% | CYTH1 | I20 | 7.68 | 0% | FADS3 | I8 | 7.83 | 61.21% | BUB3 | I7 | 7.45 | 26.62% | LRMP | I19 | 7.32 | 0% | KHSRP | I20 | 7.08 | 0% | HNRNPH1 | I1 | 6.96 | 0% | HLA-E | I3 | 5.79 | 0% | RP11-405L18.3 | I2 | 5.94 | 98.54% | CD1C | I5 | 7.09 | 0% | AC107377.1 AC005332.1 | Ix | 6.79 | 0% | CD22 | I4 | 6.48 | 0% | ATP8B1 | I17 | 6.34 | 0% | CCDC65 FKBP11 | Ix | 6.99 | 0% | SP110 | I18 | 6.23 | 0% |
| 87 | SRRM2 | I9 | 7.57 | 0% | DOK3 | I7 | 6.90 | 0% | AC073343.3 PMS2CL | Ix | 5.94 | 2187.53% | KHSRP | I20 | 6.90 | 0% | SLC25A15 | I8 | 6.80 | 0% | HNRNPH1 | I10 | 7.15 | 0% | SLC25A15 | I8 | 6.09 | 97.89% | PTPN1 | I9 | 6.65 | 0% | TMPO | I4 | 7.03 | 0% | ITGAE AC087742.1 | Ix | 6.88 | 0% | FUS | I9 | 6.47 | 0% | SATL1 | I5 | 6.61 | 0% | IGHV3-6 IGHM | Ix | 5.49 | 219.24% | PARP10 | I7 | 6.84 | 38.92% | LRMP | I17 | 7.44 | 0% | FUS | I9 | 7.68 | 0% | NUMA1 | I20 | 7.83 | 58.03% | COL5A1 | I61 | 7.44 | 79.95% | PSMA3 | I7 | 7.32 | 0% | SAMD12 AC023590.1 | Ix | 7.08 | 0% | PLD3 | I3 | 6.96 | 0% | SRGAP2 | I20 | 5.79 | 0% | AP000944.1 | I1 | 5.94 | 83.79% | AC105446.1 | I2 | 7.08 | 0% | RPL30 | I3 | 6.77 | 0% | RP11-1148L6.1 | I1 | 6.48 | 0% | RBM15 | I3 | 6.32 | 0% | CDK5RAP3 | I7 | 6.99 | 0% | NOL7 | I7 | 6.21 | 0% |
| 88 | DDX39 | I7 | 7.56 | 0% | FCRL5 | I12 | 6.90 | 0% | ADAT1 | I1 | 5.92 | 47.49% | P2RX5 | I7 | 6.90 | 0% | TRIB1 | I2 | 6.77 | 0% | RP11-154D6.1 | I6 | 7.13 | 0% | AP1S3 | I10 | 6.05 | 73.38% | GGA2 | I3 | 6.65 | 0% | MBD4 | I7 | 7.01 | 0% | CD74 | I7 | 6.87 | 0% | DIMT1L | I11 | 6.47 | 0% | CD74 | I7 | 6.61 | 0% | RP11-119K6.2 HELLS | Ix | 5.49 | 36.11% | SNRNP70 | I8 | 6.83 | 30.28% | FAM65B | I16 | 7.44 | 0% | USP34 | I78 | 7.67 | 0% | LSP1 | I21 | 7.80 | 52.29% | RP11-149B7.3 | I1 | 7.43 | 109.49% | MED1 | I17 | 7.30 | 0% | C8orf59 | I5 | 7.07 | 0% | SGK1 | I11 | 6.96 | 0% | HNRNPC | I8 | 5.78 | 0% | ITGAE AC087742.1 | Ix | 5.92 | 138.78% | METTL3 | I9 | 7.08 | 0% | SGK1 | I14 | 6.76 | 0% | KIAA0391 | I1 | 6.48 | 0% | C19orf54 | I1 | 6.31 | 0% | GNRHR2 | I2 | 6.98 | 0% | AC073343.3 PMS2CL | Ix | 6.20 | 0% |
| 89 | NXF1 | I10 | 7.56 | 0% | PABPC1 | I2 | 6.88 | 0% | AC105446.1 | I2 | 5.88 | 11104.31% | PIM1 | I3 | 6.89 | 0% | RGS2 | I1 | 6.77 | 0% | HNRNPD | I8 | 7.12 | 0% | IRF9 | I6 | 6.04 | 21.55% | AC006273.1 C19orf6 | Ix | 6.63 | 0% | PABPC1 | I2 | 7.01 | 0% | CD53 | I5 | 6.86 | 0% | REPIN1 ZNF775 RP4-584D14.2 | Ix | 6.46 | 0% | IRF8 | I3 | 6.59 | 0% | CD3EAP | I2 | 5.49 | 36.34% | SGK1 | I15 | 6.81 | 21.83% | MYL6 | I6 | 7.43 | 0% | NAP1L1 | I13 | 7.67 | 0% | DGKA | I11 | 7.79 | 31.23% | KLRK1 AC022075.1 | Ix | 7.41 | 33.00% | USP34 | I77 | 7.27 | 0% | AC010619.2 | I2 | 7.06 | 0% | RBM15 | I3 | 6.95 | 0% | FNBP1 | I23 | 5.78 | 0% | VPRBP | I28 | 5.89 | 45.24% | AC012379.2 SHC4 | Ix | 7.07 | 0% | TMC6 TMC8 | Ix | 6.75 | 0% | DNAJC4 | I6 | 6.45 | 0% | AL035670.1 | I1 | 6.31 | 0% | APC2 | I10 | 6.97 | 0% | NRP2 | I22 | 6.19 | 0% |
| 90 | SFRS3 | I3 | 7.55 | 0% | FUT11 | I5 | 6.88 | 0% | RP11-149B7.3 AL136219.3 | Ix | 5.87 | 67.55% | PIM2 | I3 | 6.89 | 0% | PCNT | I48 | 6.73 | 0% | DDX5 | I9 | 7.11 | 0% | RP11-78J21.3 | I4 | 6.03 | 194.12% | CD83 | I3 | 6.63 | 0% | IRF9 | I6 | 7.01 | 0% | POU2AF1 | I5 | 6.86 | 0% | PTPRB | I24 | 6.45 | 0% | PFKP | I21 | 6.58 | 0% | C14orf45 | I17 | 5.48 | 922.07% | TAP2 | I5 | 6.81 | 22.79% | SRRM2 | I13 | 7.42 | 0% | USP34 | I77 | 7.66 | 0% | SNRPD3 | I4 | 7.77 | 80.92% | NBEAL2 | I13 | 7.40 | 20.49% | METTL3 | I9 | 7.27 | 0% | AC096579.3 | I8 | 7.06 | 0% | NDE1 | I11 | 6.94 | 0% | HSD17B1 | I2 | 5.78 | 0% | C16orf7 | I4 | 5.88 | 292.83% | SRRM2 | I9 | 7.07 | 0% | TMC6 | I1 | 6.75 | 0% | RRP1 | I5 | 6.44 | 0% | C14orf45 | I18 | 6.30 | 0% | AC105446.1 | I2 | 6.96 | 0% | SFRS18 | I3 | 6.17 | 0% |
| 91 | CD74 | I6 | 7.54 | 0% | CASP1 | I13 | 6.88 | 0% | SP110 | I18 | 5.84 | 39.77% | KIF22 | I12 | 6.89 | 0% | CIITA | I19 | 6.71 | 0% | DENND2D | I9 | 7.10 | 0% | LL22NC03-80A10.2 | I4 | 6.03 | 59.39% | PIM1 | I6 | 6.63 | 0% | DGKZ | I29 | 7.00 | 0% | C16orf72 | I3 | 6.86 | 0% | SFRS3 | I3 | 6.44 | 0% | C20orf11 | I6 | 6.56 | 0% | AC104186.1 | I1 | 5.47 | 100.24% | PTPRB | I24 | 6.80 | 648.86% | IRF9 | I6 | 7.42 | 0% | HNRNPA1 | I10 | 7.64 | 0% | RP11-262H14.10 | I1 | 7.76 | 146.22% | ELOVL5 | I3 | 7.37 | 24.55% | DOK3 | I7 | 7.26 | 0% | BANK1 | I13 | 7.06 | 0% | ANKRD10 | I7 | 6.94 | 0% | LL22NC03-80A10.2 | I4 | 5.77 | 0% | RP11-149B7.3 AL136219.3 | Ix | 5.83 | 52.40% | BAX | I6 | 7.07 | 0% | MBD1 | I18 | 6.72 | 0% | TMC6 TMC8 | Ix | 6.43 | 0% | CALU | I9 | 6.28 | 0% | RPL41 | I1 | 6.96 | 0% | SYNGR2 | I1 | 6.17 | 0% |
| 92 | CFLAR ALS2CR10 | Ix | 7.54 | 0% | PSMA3 | I7 | 6.84 | 0% | MCOLN2 | I12 | 5.84 | 23.43% | PTPRB | I27 | 6.89 | 0% | TCTN1 | I14 | 6.71 | 0% | TRBC1 | I20 | 7.08 | 0% | ZNF266 | I6 | 6.03 | 49.19% | RPS25 | I2 | 6.62 | 0% | CD3EAP | I2 | 7.00 | 0% | ILF3 | I11 | 6.85 | 0% | SFRS18 | I3 | 6.42 | 0% | PDAP1 | I5 | 6.56 | 0% | ARHGEF18 | I20 | 5.45 | 91.18% | MBD1 | I18 | 6.80 | 52.66% | FCRL1 | I2 | 7.41 | 0% | AC012379.2 SHC4 | Ix | 7.63 | 0% | AP1G2 AL135999.3 | Ix | 7.74 | 24.18% | FNBP1 | I23 | 7.35 | 23.00% | C12orf35 | I4 | 7.26 | 0% | MYL6 | I5 | 7.04 | 0% | RP11-119K6.2 HELLS | Ix | 6.94 | 0% | CSNK2A2 | I11 | 5.76 | 0% | DIMT1L | I11 | 5.83 | 34.39% | AC096579.1 AC096579.3 | Ix | 7.06 | 0% | BAX | I6 | 6.72 | 0% | USF2 | I8 | 6.42 | 0% | AC073343.3 PMS2CL | Ix | 6.28 | 0% | NDE1 | I11 | 6.96 | 0% | AC004971.1 | I1 | 6.17 | 0% |
| 93 | AL645941.2 HLA-DMB HLA-DMA | Ix | 7.54 | 0% | AL136532.1 CTSZ | Ix | 6.82 | 0% | EMG1 | I7 | 5.81 | 27.96% | EML6 | I41 | 6.88 | 0% | ISCU | I7 | 6.68 | 0% | AK2 RP1-117O3.1 | Ix | 7.07 | 0% | ATP5S | I6 | 6.02 | 51.56% | IGHG4 | I1 | 6.61 | 0% | FAM129C | I4 | 6.99 | 0% | CD74 | I4 | 6.84 | 0% | SH3BP5 AC087590.3 | Ix | 6.42 | 0% | C14orf45 | I18 | 6.55 | 0% | AC107377.1 AC005332.1 | Ix | 5.45 | 72.35% | C19orf54 | I1 | 6.78 | 108.22% | D87015.1 SC-9C5.1 D86994.3 BCRL4 | Ix | 7.41 | 0% | DDX5 | I9 | 7.63 | 0% | AC004490.2 | I3 | 7.73 | 3851.10% | CPSF1 | I26 | 7.34 | 33.18% | DIMT1L | I11 | 7.25 | 0% | AC079923.1 | I4 | 7.04 | 0% | RBMX | I8 | 6.92 | 0% | DDX39 | I7 | 5.75 | 0% | AC003092.2 | I5 | 5.82 | 88.75% | HLA-E | I5 | 7.05 | 0% | TMC6 | I2 | 6.71 | 0% | RNFT2 | I11 | 6.42 | 0% | GNRHR2 | I2 | 6.27 | 0% | C17orf62 | I3 | 6.95 | 0% | ANKRD44 | I32 | 6.16 | 0% |
| 94 | GNB2L1 | I8 | 7.53 | 0% | ANKRD10 | I9 | 6.82 | 0% | CYTH1 | I20 | 5.79 | 26.71% | AICDA | I3 | 6.88 | 0% | RGS2 | I4 | 6.68 | 0% | UBE2H | I10 | 7.06 | 0% | AC005037.5 AC005037.9 | Ix | 6.01 | 1462.52% | MS4A1 | I4 | 6.61 | 0% | AC105446.1 | I2 | 6.99 | 0% | C17orf62 | I3 | 6.84 | 0% | SYTL3 | I4 | 6.42 | 0% | C13orf18 | I8 | 6.54 | 0% | RP11-405L18.3 | I1 | 5.44 | 71.94% | BAX | I6 | 6.75 | 32.37% | TBC1D17 | I3 | 7.40 | 0% | RBM25 | I9 | 7.63 | 0% | TCTN1 | I15 | 7.73 | 117.64% | CSNK2A2 | I11 | 7.33 | 48.38% | TAF1D | I4 | 7.25 | 0% | HNRNPH1 | I4 | 7.02 | 0% | FAM65B | I16 | 6.91 | 0% | CHIT1 | I14 | 5.73 | 0% | OSBPL10 | I3 | 5.81 | 56.03% | SEPT1 | I7 | 7.05 | 0% | DUSP1 | I2 | 6.71 | 0% | AC105446.1 | I2 | 6.41 | 0% | TIPRL | I8 | 6.26 | 0% | SYNE2 | I111 | 6.94 | 0% | COL5A1 | I65 | 6.16 | 0% |
| 95 | CTSH | I5 | 7.52 | 0% | RGS1 | I3 | 6.81 | 0% | RP11-286H14.1 | I1 | 5.78 | 1067.31% | NUDT13 | I7 | 6.87 | 0% | RNF167 | I1 | 6.64 | 0% | ACADVL | I10 | 7.06 | 0% | PARP15 | I5 | 6.00 | 20.35% | RPS24 | I5 | 6.59 | 0% | DIMT1L | I11 | 6.97 | 0% | TMEM49 | I11 | 6.82 | 0% | PABPC1 | I2 | 6.41 | 0% | TOP3A | I19 | 6.54 | 0% | RNASEH2C | I1 | 5.43 | 28.50% | CARD8 | I5 | 6.75 | 37.02% | SEPT6 | I12 | 7.40 | 0% | DUSP22 AL357054.1 | Ix | 7.63 | 0% | CLEC2D | I8 | 7.70 | 66.27% | IGHV3-6 IGHM | Ix | 7.33 | 84.40% | ATP8B1 | I17 | 7.25 | 0% | HNRNPH1 | I3 | 7.01 | 0% | UBE2H | I10 | 6.91 | 0% | HLA-F | I5 | 5.72 | 0% | RNFT2 | I11 | 5.76 | 146.63% | HNRNPH1 | I10 | 7.03 | 0% | B2M | I3 | 6.68 | 0% | PKD1L1 HUS1 | Ix | 6.41 | 0% | AC118274.1 | I3 | 6.22 | 0% | TCL1A | I3 | 6.94 | 0% | CD83 | I4 | 6.15 | 0% |
| 96 | BCAT1 | I8 | 7.52 | 0% | FTH1 | I2 | 6.81 | 0% | CDK17 | I16 | 5.77 | 104.57% | FAM65B | I16 | 6.87 | 0% | FEZF1 RP11-560I19.1 | Ix | 6.64 | 0% | AC105446.1 TRIM56 | Ix | 7.05 | 0% | CFLAR | I20 | 6.00 | 27.50% | BTN3A2 | I11 | 6.58 | 0% | RPS9 LILRA6 LILRB3 | Ix | 6.97 | 0% | PAQR3 | I10 | 6.81 | 0% | TBCE | I18 | 6.41 | 0% | FXR1 | I20 | 6.51 | 0% | DCLRE1C | I19 | 5.41 | 103.33% | MICAL2 | I27 | 6.74 | 194.98% | STAP1 | I9 | 7.40 | 0% | ACAP1 | I5 | 7.61 | 0% | RP11-262H14.6 | I1 | 7.65 | 120.60% | TRAF5 | I8 | 7.31 | 100.69% | BAX | I6 | 7.24 | 0% | SIGLEC12 | I17 | 7.01 | 0% | MICAL2 | I27 | 6.91 | 0% | ARHGEF18 | I20 | 5.71 | 0% | GNRHR2 | I2 | 5.71 | 3145.36% | C10orf104 | I4 | 6.99 | 0% | FOS | I2 | 6.66 | 0% | ANKRD44 | I32 | 6.41 | 0% | MORN1 | I1 | 6.20 | 0% | ITGAE AC087742.1 | Ix | 6.93 | 0% | FAM65B | I16 | 6.14 | 0% |
| 97 | TCIRG1 | I15 | 7.51 | 0% | PSMB7 | I12 | 6.81 | 0% | THEM5 | I3 | 5.76 | 678.17% | CDK5RAP3 | I7 | 6.87 | 0% | FEZF1 RP11-560I19.1 | Ix | 6.64 | 0% | H2AFV | I5 | 7.04 | 0% | TCIRG1 | I5 | 5.99 | 58.40% | CD74 | I6 | 6.57 | 0% | C17orf62 | I3 | 6.95 | 0% | POU2F2 | I12 | 6.80 | 0% | PTPRB | I26 | 6.39 | 0% | NAPSB | I7 | 6.51 | 0% | RNFT2 | I11 | 5.39 | 182.70% | HECW2 | I28 | 6.73 | 273.05% | CD74 | I4 | 7.40 | 0% | NAPSB | I4 | 7.61 | 0% | FAM129C | I4 | 7.64 | 37.90% | MSL3 | I9 | 7.30 | 66.57% | AC011450.2 CD37 | Ix | 7.24 | 0% | IGHV3-6 IGHM | Ix | 7.00 | 0% | RP11-264I13.1 SMARCA2 | Ix | 6.90 | 0% | C14orf153 | I27 | 5.71 | 0% | AL928742.2 | I5 | 5.71 | 37.08% | ARHGEF18 | I20 | 6.99 | 0% | AK2 RP1-117O3.1 | Ix | 6.66 | 0% | AC107377.1 AC005332.1 | Ix | 6.41 | 0% | TEX9 MNS1 | Ix | 6.19 | 0% | CPSF1 | I26 | 6.92 | 0% | C19orf54 | I1 | 6.13 | 0% |
| 98 | PCBP2 | I12 | 7.49 | 0% | TAF13 | I4 | 6.81 | 0% | SKIL | I2 | 5.76 | 34.83% | DNAJC16 | I17 | 6.87 | 0% | PDLIM3 | I4 | 6.62 | 0% | KLRK1 AC022075.1 | Ix | 7.04 | 0% | RP1-180E22.1 | I2 | 5.99 | 85.24% | SFRS6 | I2 | 6.55 | 0% | METTL3 | I9 | 6.95 | 0% | AC105446.1 | I2 | 6.79 | 0% | GNRHR2 | I2 | 6.39 | 0% | AP000944.1 | I2 | 6.50 | 0% | MCART1 | I3 | 5.38 | 82.42% | DEF6 | I5 | 6.71 | 30.51% | MS4A1 | I4 | 7.39 | 0% | RP11-262H14.10 | I1 | 7.58 | 0% | CENPT | I9 | 7.63 | 75.89% | FUS | I7 | 7.28 | 24.79% | B2M | I3 | 7.24 | 0% | SLC6A16 | I6 | 6.99 | 0% | APLNR | I1 | 6.90 | 0% | SIGLEC5 | I5 | 5.71 | 0% | SLC25A15 | I8 | 5.70 | 103.25% | EVL | I12 | 6.98 | 0% | LRRC61 | I5 | 6.66 | 0% | MORN1 | I1 | 6.41 | 0% | RP11-149B7.3 AL136219.3 | Ix | 6.18 | 0% | AC023055.2 | I3 | 6.88 | 0% | GNAI2 | I12 | 6.12 | 0% |
| 99 | IRF9 | I6 | 7.49 | 0% | IGHV3-6 | I24 | 6.80 | 0% | ACIN1 | I11 | 5.76 | 21.02% | RP11-318K12.1 | I7 | 6.87 | 0% | DERL3 | I3 | 6.62 | 0% | FAM129C | I4 | 7.02 | 0% | H2AFV | I5 | 5.99 | 28.79% | POU2F2 | I13 | 6.55 | 0% | METTL9 | I4 | 6.95 | 0% | CCL2 | I2 | 6.79 | 0% | CREBZF | I1 | 6.38 | 0% | POU2F2 | I12 | 6.50 | 0% | TP53BP1 | I32 | 5.38 | 47.87% | IRF3 | I1 | 6.71 | 22.40% | CTSH | I5 | 7.39 | 0% | UBE2H | I10 | 7.58 | 0% | LTB4R | I1 | 7.62 | 104.59% | C11orf48 | I4 | 7.28 | 76.44% | CD53 | I8 | 7.21 | 0% | RPL30 | I6 | 6.99 | 0% | CD83 | I4 | 6.89 | 0% | RNASEH2C | I1 | 5.70 | 0% | ADAT1 | I1 | 5.69 | 50.95% | METT11D1 | I9 | 6.98 | 0% | HNRPDL | I7 | 6.65 | 0% | EIF3G | I7 | 6.40 | 0% | BTF3 | I4 | 6.18 | 0% | GNAI2 | I12 | 6.88 | 0% | CIITA | I19 | 6.12 | 0% |
| 100 | SRRM2 | I13 | 7.48 | 0% | LUC7L2 | I12 | 6.79 | 0% | RP11-405L18.3 | I2 | 5.74 | 95.41% | ITGAE AC087742.1 | Ix | 6.86 | 0% | SRP9 | I3 | 6.61 | 0% | AL136532.1 GNAS | Ix | 7.02 | 0% | ORMDL1 | I1 | 5.98 | 37.70% | RP11-149B7.3 | I1 | 6.54 | 0% | SIRPB2 | I6 | 6.91 | 0% | PARP15 | I6 | 6.78 | 0% | PTPRB | I27 | 6.38 | 0% | FUS | I9 | 6.50 | 0% | PANK2 | |